










Effects of Methamphetamine on Prenatally Exposed Children in Cape Town: 
Cognition and intrinsic functional brain connectivity 
Maja Kwiatkowski 
KWTMAJ001 
A dissertation submitted in fulfillment of the requirements for the award of the degree of
Master of Arts (Clinical Neuropsychology).
ACSENT Laboratory
Department of Psychology
University of Cape Town
2014
Supervisor: Kevin Thomas 
Co-supervisors:  Jonathan Ipser and Annerine Roos 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 














This work has not been previously submitted in whole, or in part, for the award of any degree. 
Part of this thesis, the introduction, has already been published in the Journal of Metabolic 
Brain Disease; however, the introduction has been reworked for the purpose of this 
dissertation. It is my own work. Each significant contribution to, and quotation in, this 























I would like to express my deepest gratitude and thanks to my supervisor, A/Prof. Kevin 
Thomas, for his time, guidance, teaching, and support throughout this dissertation. His 
knowledge and commitment to the highest standards of academic research have inspired me 
to be a better writer, researcher, and clinician. Thank you for allowing me the space to speak 
freely during our supervision sessions, and pursue various projects without objection. I have 
grown both personally and professionally through this experience. 
 
I am also grateful to my co-supervisors, Dr Annerine Roos and Dr Jonathan Ipser for their 
guidance and dedication to this project. Thank you for imparting me with a better 
understanding of the brain through the lens of imaging research – without your expertise, I 
could not have completed this dissertation. I would also like to thank Dr Kirsty Donald for 
her mentorship throughout this project – thank you for your confidence in me, words of 
wisdom, and always encouraging me to pursue my passion. I further wish to express my 
profound appreciation to the mothers, caregivers, and children who participated in this 
research. 
 
This study was undertaken with generous support from the Harry Crossley Foundation, and 
Thuthuka funding from the National Research Foundation, obtained by the MRC Unit of 









ACC   Anterior cingulate cortex 
ADC   Apparent diffusion coefficient 
ADHD  Attention-deficit/hyperactivity disorder 
AFNI  Analysis of Functional Neuroimaging 
BA   Brodmann areas 
BNT-SA-SF Boston Naming Test (South African Short Form) 
BOLD  Blood oxygen level-dependent 
CN   Caudate nucleus 
CNS   Central nervous system 
CPRS  Conners' Parent Rating Scale 
Cr    Creatine 
CUBIC Cape Universities Brain Imaging Centre 
DA   Dopamine 
DMN  Default mode network 
DTI   Diffusion tensor imaging 
EPI   Echo planar imaging 
ESE   Estimate of effect size 
fMRI   Functional magnetic resonance imaging 
fMRIb  Functional magnetic resonance imaging of the brain 
FSL   Functional Magnetic Resonance Imaging of the Brain Software Library 
GLM   General linear model 
FWHM Full width at half maximum 
GLX   Glutamate + glutamine 
GPT   Grooved Pegboard Test 
HC   Healthy controls 
HPCSA Health Professionals Council of South Africa 
ICA   Independent Component Analysis 
IDEAL Infant Development, Environment, and Lifestyle 
IPC   Inferior parietal cortex 
IQ    Intelligence quotient 
KABC-II Kaufman Assessment Battery for Children (Second Edition) 
MA   Methamphetamine 
MAO  L-Monoamine oxidase 
MELODIC Multivariate Exploratory Linear Decomposition into Independent   
    Components 
MP-RAGE Magnetization-prepared rapid acquisition with gradient echo 
MI   Myoinositol 
MRI   Magnetic resonance imaging 
MRS   Magnetic resonance spectroscopy 
NA   N-acetyle  
NE   Norepinephrine 
NVI   Nonverbal Index 
NVS   Nonverbal Scale 
PAL   Paired Associate Learning 
PCC   Posterior cingulate cortex 
PME   Prenatal methamphetamine exposure 
  
5 
RA   Research Assistant 
RS-fMRI Resting state functional magnetic resonance imaging 
RSNs  Resting state networks 
RXH   Red Cross Children‟s Hospital 
SA   South Africa 
SACENDU South African Community Epidemiology Network on Drug Use 
SES   Socioeconomic status 
sMRI  Structural magnetic resonance imaging 
tCR   Total creatine 
TH   tyrosine hydroxylase 
UCT   University of Cape Town 
VMI   Visual motor integration 
WISC  Wechsler Intelligence Scale for Children 
WM   White matter 
WPPSI Wechsler Preschool and Primary Scale of Intelligence 
ZAR   South African Rand 




















Table of Contents 
 
List of Figures……………………………………………………………………………….11 
List of Tables………………………………………………………………………………..12 
Abstract……………………………………………………………………………………...14 
Introduction…………………………………………………………………………....…….15 
 Methamphetamine Abuse in Cape Town: Epidemiology, risks and consequences 
 ……………………………………………………………………………………………15 
 Affective, Behavioral, and Cognitive Outcomes………………………………...………17 
 Effects of Methamphetamine on Developing Neural Circuitry………………………….21 
 Human Magnetic Resonance Imaging Studies of Prenatal Methamphetamine Exposure  
 ……………………………………………………………………………………………25 
  Structural and Metabolic Neuroimaging Findings……………………………...…….25 
  Functional Neuroimaging Findings…………………………………………………...29 
  Resting-state Neuroimaging………………………………………………..…………32 
  Structure-function Correlations……………………………………………………….33 
 Challenges in Prenatal Drug Exposure Research……………………………...................34 
 Summary and Conclusion……………………………………………………..…………36 
 Rationale, Specific Aims, and Hypotheses…………………………………...………….37 
Methods……………………………………………………………………………………..39 
 Design and Setting……………………………………………………………………….39 
 Participants……………………………………………………………….………………39 
  Recruitment and Eligibility Criteria…………………………………………………..39 
 Measures…………………………………………………………………………………40 
  Sociodemographic Questionnaire…………………………………………………….40 
  
7 
  Drug Intake Questionnaire…………………………………………………..……….41 
  The Beery Developmental Test of Visual-Motor Integration……………..................41 
  Kaufman Assessment Battery for Children - Second Edition……………………….42 
   Hand Movements…………………………………………………………………..43 
   Block Counting………………………………………………………………....….43 
   Conceptual Thinking…………………………………………………………....…43 
   Triangles……………………………………………………………………...……43 
   Pattern Reasoning……………………………………………………………….....44 
   Story Completion…………………………………………………………………..44 
   Atlantis…………………………………………………………..............................44 
   Atlantis Delayed………………………………………………………………...….45 
  Boston Naming Test (South African Short Form)…………………………………..45 
  Grooved Pegboard Test………………………………………………………….......45 
 Procedure………………………………………………………………………..…...…46 
  Phase I…………………………………………………………………..………...…46 
   Image Acquisition………………………………………………………………….47 
  Phase II………………………………………………………………………………48 
   Neurocognitive Assessment……………………………………………………….48 
 Ethical Considerations……………………………………………………………….…49 
 Data Management and Statistical Analyses……………………………………………51 
  Neuropsychological Data Preprocessing and Analysis………………….………….51 
  fMRI Data Preprocessing and Analysis…………………………………………….52 
   Preprocessing…………………………………………………………….………..52 
   Independent Component Analysis (ICA)…………………………………………53 
   Dual Regression Analysis………………………………………………………...54 
  
8 
   Between-group Comparisons…………………………………………………….55 
Results……………………………………………………………………………………55 
 Child Sample Characteristics…………………………………………………………55 
  Sociodemographic variables………………………………………………………56 
  Anthropometric Information………………………………………………………56 
 Maternal Sample Characteristics……………………………………………………..58 
 Cognitive Outcomes………………………………………………………………….58 
  Hypothesis 1………………………………………………………………………58 
 Secondary Analyses………………………………………………………………….62 
 Hierarchical Regression Analysis……………………………………………………63 
  Hypothesis 2……………………………………………………………................63 
  Model 1: Predicting performance on the KABC-II Non-Verbal IQ score………..65 
  Model 2: Predicting performance on the KABC-II Sequential Processing subtest 
  …………………………………………………………………………………….66 
  Model 3-5: Predicting performance on the KABC-II Simultaneous Processing  
  subtests. ………………………………………………………………………….67 
   Model 3: Conceptual Thinking…………………………………………………67 
   Model 4: Block Counting………………………………………………………68 
   Model 5: Triangles……………………………………………………………..68 
  Model 6-7: Predicting performance on the KABC-II Planning Ability subtests...70 
   Model 6: Story Completion…………………………………………………….70 
   Model 7: Pattern Reasoning…………………………………………………….71 
  Model 8-9: Predicting performance on the KABC-II Learning Ability subtests 
  ……………………………………………………………………………………71 
   Model 8: Atlantis……………………………………………………………….71 
  
9 
   Model 9: Atlantis Delayed……………………………………………………...71 
  Model 10: Predicting performance on the BNT-SA-SF………………………….72 
  Model 11-13: Predicting performance on the Beery VMI subtests………………73 
   Model 11: Beery VMI…………………………………………………………..73 
   Model 12: Beery Visual Perception Test……………………………………….75 
   Model 13: Beery Motor Co-ordination Test……………………………………75 
  Model 14-15: Predicting performance on the GPT variables…………………….75 
   Model 14: GPT Insertion Time, dominant hand………………………………..75 
   Model 15: GPT insertion time, non-dominant hand…………………………....75 
 Imaging Analyses……………………………………………………………………77 
  Sample Characteristics……………………………………………………...……77 
  Independent Component Analysis Outcomes…………………………………….80 
   Testing for between-group differences in motion………………………………82 
   Examining between-group differences in network connectivity…………….....82 
Discussion………………………………………………………………………………87 
 Impaired Cognitive Functioning in Children with PME………………………….…87 
  Hypothesis 1……………………………………………………………………...87 
   General Intellectual Functioning……………………………………………….88 
   Learning and Memory………………………………………………………….90 
   Language……………………………………………………………………….91 
   Visual-motor integration……………………………………………………….91 
   Fine motor co-ordination………………………………………………………92 
 Relationship between PME and Neuropsychological Outcomes when Controlling for 
 Potential Confounding variables……………………………………………………93 
  Hypothesis 2……………………………………………………………………..94 
  
10 
   Child‟s Age at Testing………………………………………………………….94 
   Maternal Level of Education…………………………………………………...94 
 Disrupted Functional Connectivity in Children with PME………………………….95 
  Hypothesis 3………………………………………………………...……………95 
   Basal Ganglia Network…………………………………………………………96 
   Default Mode Network…………………………………………………………98 
   Salience Network……………………………………………………………….99 
   Sensorimotor Network……………………………………………………...…100 
   Interim Summary……………………………………………………………...101 
 Limitations and Directions for Future Research…………………………….……..102 

















List of Figures 
 
Figure 1. Frost and Cadet‟s (2009) schematic of the effects of MA on neural circuitry.……23 
Figure 2. Schematic of RS-fMRI preprocessing pipeline………………………....................53 
Figure 3. Schematic of independent components analysis of fMRI data……………………54 
Figure 4. RSNs of interest identified in the 35-component independent component 
analysis……………………………………………………………………………………….81 
Figure 5. Significant between-group differences identified in the resting state networks of 
interest………………………………………………………………………………………..84 


















List of Tables 
 
Table 1. Structural and Metabolic MRI Findings in PME…………………………………...27 
Table 2. Functional MRI Findings in PME………………………………………………….30 
Table 3. Cognitive Outcome Variables…………………………………................................41 
Table 4. Demographic and Anthropometric Sample Characteristics for Participants and 
Mothers (N = 45)…………………………………………………………………………….57 
Table 5. Results for Tests of Normality and Homogeneity of Variance for Cognitive Variables 
(N = 45)……………………………………………………………………………….……..59 
Table 6. Cognitive Outcome Variables: Descriptive statistics and between-group 
comparisons (N = 45)……………………………………………………………….….……61 
Table 7. Correlations for Cognitive Outcomes and Potential Confounding Variables (N 
=45)…………………………………………………………………………………….……64 
Table 8. Hierarchical Regression Model 1: Performance on the KABC-II NVI, predicted by 
potential confounding variables and group status (N = 45)………………………………...66 
Table 9. Hierarchical Regression Model 2: Performance on the KABC-II Sequential 
Processing subtests, predicted by potential confounding variables and group status (N = 
45)……………………………………………………………………………………………67 
Table 10. Hierarchical Regression Models 3-5: Performance on the KABC-II Simultaneous 
Processing subtests, predicted by potential confounding variables and group 
status…………………………………………………………………………………………69 
Table 11. Hierarchical Regression Models 6-7:Performance on the KABC-II Planning Ability 




Table 12. Hierarchical Regression Models 8-9: Performance on the KABC-II Learning 
Ability subtests, predicted by potential confounding variables and group status (N = 
45)…………………………………………………………………………………………….72 
Table 13. Hierarchical Regression Model 10: Performance on the BNT-SA-SF, predicted by 
potential confounding variables and group status (N = 45)………………………………....73 
Table 14. Hierarchical Regression Models 11-13: Performance on the Beery VMI, predicted 
by potential confounding variables and group status (N = 45)…………………………...…74 
Table 15. Hierarchical Regression Models 14-15: Performance on the GPT, predicted by 
potential confounding variables and group status (N = 45)……………………………...….76 
Table 16. Demographic and Anthropometric Sample Characteristics, for Participants and 
Mothers (N = 26)…………………………………………………………………………….78 
Table 17. Cognitive Outcome Variables: Descriptive Statistics and Between-Group 
Comparisons (N = 26)……………………………………………………………………….79 














 Methamphetamine use among pregnant women is an increasing problem in South 
Africa. The aim of this cross-sectional exploratory study was to examine the possible 
neurotoxic effects of prenatal methamphetamine exposure (PME) on cognition and the 
developing brain in a sample of affected children in Cape Town, South Africa. Thus, this is a 
two-part study: the first part examines the effects of PME on neuropsychological outcomes, 
and the second part examines the effects of PME on intrinsic functional brain connectivity. 
Children with PME (n = 23) and unexposed controls (n = 22) completed a battery of 
neurocognitive assessments, and a smaller sub-sample (n = 36; 19 children with PME, 17 
unexposed controls) also underwent resting-state functional magnetic resonance imaging 
(RS-fMRI). Independent samples t-tests revealed that children with PME scored significantly 
more poorly on measures of IQ, learning and memory, confrontation naming, visual-motor 
integration, and fine motor co-ordination, when compared to controls. Hierarchical regression 
analyses confirmed that PME has a significant effect on cognitive performance, and that this 
effect largely withstands the effects of potentially confounding sociodemographic and 
anthropometric variables. Independent component analyses revealed significant between-
group differences in functional brain networks detected in task-free RS-fMRI in children with 
PME. Specifically, there is evidence for compromised connectivity within and between the 
basal ganglia network and default mode network in children with PME. Overall, the findings 
contribute to the small but growing literature on the cognitive effects of PME. The current 
study is the first to document preliminary evidence indicating aberrant intrinsic functional 
brain connectivity in children with PME, and suggests that further investigation of potential 
associations between particular neurocognitive deficits and such aberrant connectivity might 
be warranted. 
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With over 250 million users worldwide, methamphetamine (MA) has become a 
significant public health concern (United Nations Office on Drugs & Crime, 2010). The 
global rise in MA abuse during pregnancy has rendered a large number of infants and 
children at risk for the adverse consequences of prenatal methamphetamine exposure (PME; 
Meredith, Jaffe, Ang-Lee, & Saxon, 2005). Emerging evidence suggests that PME affects 
fetal growth and may lead to a variety of developmental, behavioral, and neurological 
abnormalities (Abar et al., 2013a; Nguyen et al., 2010). However, outside of animal studies, 
very little is known about the extent of the medium- and long-term functional and structural 
effects of MA exposure in utero. This study aims to contribute to the small but accumulating 
body of research delineating the longer-term clinical outcomes of PME. 
Methamphetamine Abuse in Cape Town: Epidemiology, risks, and consequences 
MA abuse is the fastest growing illicit drug problem worldwide (Wouldes et al., 
2013). In the United States, the Treatment Episode Data set that captures admissions to 
federally funded treatment centers reported that admissions for pregnant women using MA 
increased from 8% in 1994 to 23.7% in 2006 (Terplan, Smith, Kozloski, & Pollack, 2009). 
These findings are corroborated in Cape Town, the largest city in the Western Cape province 
of South Africa (population approximately 3 700 000), which has experienced a significant 
increase in MA abuse over the past decade (Meade et al., 2012). 
Recently, the South African Community Epidemiology Network on Drug Use 
(SACENDU) reported that, since 2004, MA has become the primary drug of choice in the 
Western Cape, with 70% of MA users falling under the age of 20 (Van Heerden et al., 2009). 
Reports from treatment centers in Cape Town indicate that the proportion of patients with 
MA as their primary substance of abuse increased from less than 1% in 2000 to 
approximately 34% in 2010 (Plüddemann, Parry, Bhana, Dada, & Fourie, 2010). 
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Although MA use is cause for concern in both sexes, South African social history and 
structure (both socioeconomic and cultural) has facilitated a context that predisposes women, 
particularly those living in historically disadvantaged communities, to associated risks (Kapp, 
2008; Morris & Parry, 2006; Wechsberg et al., 2008a, 2008b). For example, because MA 
users frequently engage in high-risk sexual behaviors (e.g., having unprotected sex with 
multiple partners, working in the sex trade), female users are at greater risk for unplanned 
pregnancy (Simbayi et al., 2006; Wechsberg et al., 2010). Once pregnant, their addiction, and 
subsequent chronic fetal exposure to MA, often continues (Petersen, Jordaan, Mathews, 
Lombard, & Parry, 2013).
In a recent study exploring drug use in pregnant and non-pregnant women in a 
community sample in Cape Town, Jones et al. (2011) found that 92% of the pregnant sample 
(n = 26; age range = 18-33 years, M = 22.70, SD = 3.60) reported recent use of MA; 67% of 
the non-pregnant sample (n = 356; age range = 18-33 years, M = 24.30, SD = 4.30) also 
reported recent use. Many of the pregnant women reported having made attempts to stop or 
to reduce their drug intake after learning that they were pregnant; however, more than 30% of 
them continued to use MA at the same level, or increased their use. 
The consequences of continued MA use during pregnancy have been documented in 
earlier studies. Longitudinal data have revealed a greater number of complications in 
pregnancy (including low maternal weight gain, increased premature delivery, and neonatal 
mortality) of women who had been unable to discontinue MA use during the first trimester, 
relative to those who had terminated use (Eriksson et al., 1981). Speculated reasons for 
continued and/or increased drug use during pregnancy relate to psychiatric comorbidity, 
partner conflict or abuse, availability of social support, and utilization of treatment services 
(Roberts & Pies, 2011; Semple, Zians, Strathdee, & Patterson, 2007). A recent international 
study found that women who decreased their use of MA over the course of pregnancy 
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attended a greater number of prenatal care visits (Della Grotta et al., 2010). It is possible that 
prenatal care might have an impact on reducing MA use; alternatively, pregnant women who 
decrease their MA use are simply more likely to visit prenatal care providers. 
Pregnant women who live in low-income communities in SA do not usually seek (or 
have access to) regular antenatal care, and often report that they are unaware of drug 
treatment options (Myer & Harrison, 2003). Moreover, lack of psychoeducation around, and 
awareness of, the potential effects of PME on the developing fetus is widespread. As clinical 
studies have demonstrated, these effects can include decreased weight, length, and head 
circumference upon birth (Little, Snell, & Gilstrap, 1988; Nguyen et al., 2010; Smith et al., 
2006), as well as compromised neonatal behavioral outcomes (e.g., poor feeding, abnormal 
sleep patterns, under-arousal, and reduced movement scores; LaGasse et al., 2011; Smith et 
al., 2003, 2006). These deleterious effects may be compounded by the types of poor health 
behaviors, such as poor nutrition and increased likelihood of exposure to violence in utero, 
that are frequently associated with maternal drug use (Behnke et al., 2013). Thus, the effects 
of PME on the fetus, and on ongoing development, are of increasing concern. 
 
Affective, Behavioral, and Cognitive Outcomes 
There is a small literature on long- and short-term outcomes of PME in humans. The 
most extensive follow-up data on affective, behavioral, and cognitive outcomes following 
PME are provided by Swedish researchers who tracked a cohort of 65 MA-exposed children 
from birth to age 14 years. They have reported, in that cohort of children with continuous 
MA exposure throughout gestation, a variety of adverse physical, cognitive, emotional, and 
social effects, including increased prevalence of attention-deficit/hyperactivity disorder 
(ADHD), aggression, and learning difficulties attributed to deficits in attention, memory, and 
motivation (for a timeline of findings, see Eriksson et al., 1978, 1981, 1989, 1994, 1994a, 
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1994b, 2000). In that cohort, the first few months of life were marked by signs of drowsiness 
and lethargy (Billing, Eriksson, Larsson, & Zetterström, 1980). By the age of 1 year, the 
children began showing affective characteristics of autism, speech impediments, and signs of 
wariness of strangers. At age 4, IQ was lower than that of population controls (Billing, 
Eriksson, Steneroth, & Zetterström, 1988), and at age 8 prenatal exposure predicted 
aggressive behavior towards peers (Billing, Eriksson, Jonsson, Steneroth, & Zetterström, 
1994). By the age of 14, the children showed delays in math and language performance, and 
difficulties with physical fitness appeared to affect academic advancement (Cernerud, 
Eriksson, Jonsson, Steneroth, & Zetterstrom, 1996). Despite the robust database of behavioral 
profiles generated by research on this Swedish cohort, issues around some key 
methodological aspects (e.g., lack of a control group and uncontrolled-for confounding drug 
exposures) limit the strength of possible interpretations. 
Given the presence of those methodological issues with the Swedish research, the 
ongoing Infant Development, Environment, and Lifestyle (IDEAL) study (Della Grotta et al., 
2010), is the first and largest systematically controlled study of neurobehavioral outcomes in 
prenatally MA-exposed children. The IDEAL study, which uses cohorts from New Zealand 
and America, was the first to publish dose-response and trimester-related effects (validated 
by meconium testing) in prenatally MA-exposed children (LaGasse et al., 2011). From birth 
to 36 months, heavy PME was related to lower arousal, increased lethargy, and greater levels 
of physiological stress. In particular, first-trimester MA use was associated with greater 
physiological and central nervous system (CNS) stress, and third-trimester use with more 
lethargy and hypotonicity.  
Data from the IDEAL study have also been used to examine the effects of prenatal 
MA exposure on motor and cognitive development in children between the ages of 1 and 3 
years (Smith et al., 2011). At 1 year, children with PME presented with subtly impaired fine 
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motor performance, with the greatest disturbances observed in children with heavy PME. At 
age 3, however, both high- and low-dose groups presented with no PME-related motor 
impairment. So far, these findings yield inconsistent results in relation to some of the 
cognitive-behavioral evidence from neuroimaging studies (discussed under Structure-
Function Correlations below). For example, Chang et al. (2009) found significantly impaired 
performance on tasks of visuomotor integration in children with PME at the age of 4 years. It 
is possible that the reported differences are a factor of time, and that long-term follow-up of 
the visual-motor functioning of children in the IDEAL study will reveal comparable results.  
Discrepancies in PME-related findings have also been observed within and across the 
IDEAL study in relation to behavioral outcomes. One recent IDEAL publication (LaGasse et 
al., 2012) reported on the behavioral assessment of an older cohort of prenatally MA-exposed 
children (ages 3 and 5 years). Controlling for normal developmental trajectories, PME was 
related to heightened emotional reactivity and more anxious/depressive symptoms at both 
ages, and with externalizing and ADHD problems at age 5. Both withdrawn behavior and 
attention problems were associated with heavy PME at ages 3 and 5. Although this research 
is consistent with data from the Swedish cohort, which reported aggressive behavior, 
attentional issues, and adjustment problems at the age of 8 years (Billing et al., 1994), 
LaGasse et al.‟s findings were not replicated in a follow-up IDEAL study that used an older 
(age = 7.5 years) cohort of children (Diaz et al., 2014). In fact, Diaz et al. found no 
association between PME and behavioral problems, as measured by indices of oppositional 
behavior, hyperactive behavior, and ADHD.  
Diaz et al. (2014) proposed that the behavioral and attention difficulties identified by 
LaGasse et al. (2012) could have dissipated with age or environmental factors. However, this 
explanation does not account for the confounding findings in Billing et al.‟s  (1994) cohort, 
aged 8 years, or a more recently published study (independent from the IDEAL study), which 
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reported that the frequency of an ADHD diagnosis was four-fold more common in children 
(aged 7-9 years) with PME (Piper et al., 2011). It is possible that the differences in findings 
can be accounted for, in part, by methodological inconsistencies. In particular, the latter 
IDEAL study derived data from parent reports, whereas the earlier IDEAL study used child-
based measures.  
Despite the noted incongruities in some of the studies discussed so far, there are some 
consistencies. PME has been associated with an increased incidence of cognitive problems, 
specifically on parental ratings of executive functioning (including working memory, impulse 
regulation, goal-setting, flexibility, and emotional control; Diaz et al., 2014; Piper et al., 
2011). As mentioned earlier, PME is also associated with poor school performance (Cernerud 
et al., 1996), and so the identified cognitive impairments are likely contributing factors to the 
lack of academic success present in exposed children. Additionally, cognitive problems 
linked to inattention predict negative externalizing behaviors during childhood, possibly due 
to the relatively high levels of frustration, lack of motivation, and confusion that exposed 
children may experience (Hill, Degnan, Calkins, & Keane, 2006). Twomey et al. (2013) 
found that home environments that were more stable and sensitive to the emotional and 
developmental needs of children with PME were associated with decreased risk of 
internalizing and externalizing behavioral problems. This finding, however, was independent 
of MA exposure (the control group displayed similar behavioral challenges), thus placing the 
child‟s behavioral problems in the context of the larger family system. 
Overall, evidence from the above studies suggests that the adverse developmental 
effects experienced by children with PME are due either to the effects of the drug, the 
environment in which these children are raised, or, most likely, a combination of these factors. 
Furthermore, it is clear that PME results in changes in affect, behavior, and cognition; the 
severity and extent of these changes is likely to be modulated by the timing, dose, and route 
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of MA exposure, however. To better understand the effects of PME on childhood 
development, the potential mechanisms of action and toxicity of MA (and how they translate 
to changes in developing neural circuitry) must be explored. 
 
Effects of Methamphetamine on Developing Neural Circuitry  
MA is one of a group of sympathomimetic drugs that stimulate the CNS. It passes 
readily through the placenta and the blood-brain barrier, and can have significant 
vasoconstrictive effects on the developing fetus, resulting in decreased uteroplacental blood 
flow and fetal hypoxia (Golub et al. 2005; Won, Bubula, McCoy, & Heller, 2001). Although 
the biochemical mechanisms of action and toxicity of MA for the adult brain have been well 
documented (see Cruickshank & Dyer, 2009; Kish, 2008; Scott et al., 2007), the effects of 
PME on the organization of developing neural circuitry, and whether/how subsequent 
recovery from those effects is possible, is unclear (Sowell et al., 2010). Furthermore, because 
of the multiple interactions among developing neuronal systems that determine the 
organization of brain circuitry, the effects of MA on neural connectivity in the immature CNS 
are likely to be different to those in adults.  
The development of neural networks is influenced by numerous morphogenetic 
events, including proliferation, migration, differentiation and apoptosis, neurite growth, 
synaptogenesis, and neuronal pruning. These events are modulated by, among other factors, 
pre- and post-synaptic electrical activity, neurotrophic factor signaling, and multiple 
neurotransmitter systems (Frost & Cadet, 2000). With specific regard to the latter, the 
primary monoaminergic pathways (i.e., those using norepinephrine (NE), dopamine (DA), 
and serotonin (5HT)) project widely and develop early. This spatial and temporal 
arrangement allows these pathways to modulate the development of non-aminergic neural 
elements and the connections between them. Thus, damage to monoaminergic neurons in 
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utero may have a secondary effect on a wide variety of neural circuits (see Figure 1). 
Regarding the effects of the acute and chronic MA exposure on mature serotonergic, 
dopaminergic, and glutaminergic axons, a substantial body of literature, encompassing both 
animal and human studies, suggests multiple mechanisms of action (Barr et al. 2006; Nordahl, 
Salo, & Leamon, 2003; Scott et al., 2007; Sulzer, Sonders, Poulsen, & Galli, 2005). The 
principal mechanism by which MA stimulates the excessive release of monoamines 
(primarily, DA) includes the redistribution of catecholamines from synaptic vesicles to the 
cytosol (Brown, Hanson, & Fleckenstein, 2001) and the reverse transport of 
neurotransmitters through plasma membrane transporters (Khoshbouei, Wang, Lechleiter, 
Javitch, & Galli, 2003). There is also evidence that MA blocks the catabolism of 
catecholamines by inhibiting the activity of mitochondrial monoamine oxidase (MAO), and 
by increasing the activity and expression of the dopamine-synthesizing enzyme tyrosine 
hydroxylase (TH) (Schmitz, Lee, Schmauss, Gonon, & Sulzer, 2001; Sulzer et al., 2005). As 
a result of these multiple mechanisms, MA acts as a highly potent releaser of monoamines, 
giving rise to MA-induced neurotoxicity. This neurotoxicity is evident in several 
neurotransmitter systems, but is most notable in the nigrostriatal dopaminergic pathways. 
Thus, it is possible that PME potentially alters the function of the dopamine-rich fronto-
striatal-thalamocortical loops (Cass, 1997). 
Given these effects of MA on mature monoaminergic pathways, it is reasonable to 
suggest that developing monoaminergic neurons may also be susceptible to MA-induced 
neurotoxicity (Cadet & Krasnova, 2009). In rat studies, TH (responsible for the conversion of 
L-tyrosine to L-DOPA, a precursor for DA) has been identified as an effective marker in
assessing potential effects of MA on developing DA systems (Gomes-da-Silva et al., 2002). 
The action of TH early in CNS development is associated with the differentiation of neuronal 
groups, and with neurochemical processes that control axonal guidance, neuronal recognition, 
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and synaptogenesis (Flames & Hobert, 2011). Because TH levels appear to be reduced 
permanently following repeated MA administrations in rat pups, it is possible that the action 
of MA on TH gene expression early in development might affect critical processes related to 
dopaminergic activity (Graham et al., 2011, 2013). Specifically, MA-induced depletion of 
TH appears to alter the pattern of maturation of dopaminergic TH-containing neurons in the 
dorsal striatum, prefrontal cortex, nucleus accumbens, and substantia nigra (Kaewsuk, Sae-
ung, Phansuwan-Pujito, & Govitrapong, 2009). Such findings have been replicated in several 
rat studies, suggesting that the functional consequences of PME might result from effects on 
the mesolimbic dopaminergic pathway (Bubenikova-Valesova et al., 2009; Suzuki et al., 
2003). 
 
Figure 1.Schematic diagram of how methamphetamine, by virtue of its effects on the serotoninergic 
(5HT), dopaminergic (DA) or glutamatergic (GLU) systems, can modulate the development of non-
aminergic neural circuitry. The notation „+/- lesions‟ indicates that methamphetamine-induced 
modulation of signaling in the glutamate, serotonin, and dopamine systems is not necessarily 
accompanied by overt destruction of neurons or their processes in these systems. Reproduced with 





The evidence reviewed above is drawn from rat studies involving multiple high-dose 
exposures to MA throughout periods of fetal development. However, even single-dose MA 
exposure in utero may have significant developmental consequences. Jeng, Wong, Ting-A-
Kee, and Wells (2005) found that a relatively low dose (20 or 40 mg/kg ip, resulting in 
similar concentrations observed in premature infants born to MA-abusing mothers) of MA 
administered once-off during the embryonic or fetal period in pregnant rats caused oxidative 
DNA damage in the brain, and long-standing (potentially permanent) postnatal functional 
deficits. Of note here is that these functional deficits arose without any concomitant 
alterations in dopaminergic nerve terminal density (evidenced by staining for TH). Taken 
together, these results suggest that even single-dose PME may have negative developmental 
consequences, and that the mechanisms underlying these effects might be distinct from those 
arising from multiple-dose schedules. 
Given the plasticity of the developing brain (Andersen, 2003; Johnston et al., 2009), 
one may infer that neurological insult associated with PME would be compensated for more 
effectively than that associated with adult exposure. However, the molecular and 
morphological changes that take place during development seem to bring about windows of 
selective vulnerability, even while allowing compensatory repair mechanisms to function 
(Jeng et al., 2005; Stanwood & Levitt, 2004; Vaccarino & Ment, 2004). For example, it is 
possible that striatal dopaminergic neurons may continue to develop even after PME, but that 
their development may occur aberrantly. This aberrant development might involve atypical 
processes of neural patterning and/or remodeling in addition to, or instead of, dopaminergic 
cell loss (Jeng et al., 2005). Although further research is needed to validate these claims, it 
seems clear that the mechanisms of action in PME are a combination of the interaction of 
MA with monoaminergic neurotransmitter systems in the developing fetal brain, as well as 
with changes in brain morphogenesis (Cui et al., 2006; Won et al., 2001). 
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Human Magnetic Resonance Imaging Studies of Prenatal Methamphetamine Exposure  
To investigate the above-mentioned changes in brain morphogenesis in children with 
PME, several studies have used magnetic resonance imaging (MRI). MRI is a safe, non-
invasive technology that is often used to study brain structure and function. It uses magnet 
and radio waves to measure signals from protons (water) within the brain (Lebel, Roussotte, 
& Sowell, 2011). The signal measured is dependent on various tissue properties, including 
density, local environment, blood oxygenation, water movement, and relaxation properties 
(i.e., T1- and T2-weighted images). Different contrast mechanisms allow for several different 
types of imaging modalities, including structural MRI (sMRI), functional MRI (fMRI), 
diffusion tensor imaging (DTI), and magnetic resonance spectroscopy (MRS; see Roussotte, 
Soderberg, & Sowell, 2010 for a summary of MR-based imaging techniques). Each study 
discussed in the sections below features the use of at least one of these imaging techniques; 
however, there is little consistency in the outcomes reported by these papers, the results of 
which cannot be easily synthesized. For this reason, the end of this part of the review is 
followed by a discussion of the challenges associated with research in the area of PME. 
Structural and metabolic neuroimaging findings. A literature search revealed six 
studies that reported the use of structural and metabolic MRI to examine the effects of PME 
on brain structure and function. The first of these was published in 2001. These studies range 
in sample size from 12-49 prenatally methamphetamine-exposed subjects, and they use a 
variety of analytic methods. Table 1 presents the basic methodological details and the 
findings of each of the six studies. 
Because striatal structures have the highest densities of dopaminergic synapses, one 
might predict that the neurotoxic effects of MA would be pronounced in these regions 
(Chang, Alicata, Ernst, & Volkow, 2007). Using sMRI, Chang et al. (2004) confirmed this 
prediction: They found that, compared to unexposed age-matched controls, children exposed 
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to MA in utero showed significant regional volumetric reductions in the globus pallidus and 
putamen, and marginal decreases in caudate size. They also found significant volumetric 
reductions in the hippocampus bilaterally. Sowell et al. (2010) replicated these findings in an 
sMRI study that compared the brain morphometry of children with PME to that of children 
with prenatal alcohol exposure. They found that, although both groups of children showed 
widespread volumetric reductions (including in striatal, thalamic, prefrontal, and 
occipitoparietal regions) and some volumetric increases in limbic structures, MA-exposed 
children showed more severe volume reductions in the striatum, and more pronounced 
volumetric increases in limbic structures such as the anterior and posterior cingulate and the 
inferior frontal gyrus. 
A recent publication using a sub-sample from the present study found significant 
increases in left putamen volume (Roos, Jones, Howells, Stein, & Donald, 2014), which is 
consistent with findings on adult MA exposure (Change et al., 2005). Although the above 
findings are contradictory in terms of directionality of volumetric changes found by Chang et 
al. (2004) and Sowell et al. (2010), these data suggest aberrant processes in the dopaminergic 
system. Thus, cumulatively, these findings are not only generally consistent with predictions 
derived from the rat studies reviewed above, but they are also consistent with research 
showing that striatal and limbic structures are sites of neurotoxicity in adult MA users (Sulzer 
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7-8 (M = 7.30, SD = 1.10) 
   ↑tCr in striatum  
Chang et 
al., 2004 
sMRI 13 PME 
 
15 HC 
3-16 (M = 6.9, SD = 3.50) 
 
3-15 (M = 7.8, SD = 3.20) 





Poorer performance on 
measures of visual motor 
integration, attention, verbal 




MRS 49 PME 
 
49 HC 
3-4 (M = 3.91, SD = 1.07) 
3-4 (M = 3.76, SD = 0.99) 
↑tCR, NA, GLX 
in frontal WM 
  ↓MI in 
thalamus 
↓MI in thalamus correlated 
with poor performance on a 
task of visual-motor 
integration 
Cloak et al., 
2009 
DTI 29 PME 
 
37 HC 
3-4 (M = 4.03, SD = 1.20) 
3-4 (M = 3.98, SD = 1.40) 
↓ADC in WM 
tracts 
 ↓ADC in WM 
tracts 
↑Ch in striatum  
Sowell et 
al., 2010 
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↑V putamen  
Note. Only significant results are included in the table. MRS = magnetic resonance spectroscopy; sMRI = structural magnetic resonance imaging; DTI = diffusion tensor 
imaging; PME = prenatal methamphetamine exposure, HC = healthy controls, V = volume, ADC = apparent diffusion coefficient, WM = white matter, tCr = total creatine, 




To my knowledge, the three studies reviewed above are the only published sMRI 
studies investigating the effects of PME on the brain. Despite some consistency in findings, 
the etiology of the observed changes in volume (both reductions and increases) is not entirely 
clear. For instance, it is possible that volume increases in the anterior and posterior cingulate 
and other associated limbic cortices may serve as a compensatory mechanism for PME-
associated reductions in the dopamine-rich striatal and thalamic structures (Sowell et al., 
2010). Alternatively, the PME-related volume increases observed by Roos et al. (2014) may 
represent an aberrant process due to inadequate synaptic pruning and/or reduced myelination 
– processes that are known to continue throughout childhood to facilitate more efficient 
cognitive processing (Sowell et al., 2004).  
To date, only one published study has examined microstructural brain changes 
following PME in humans. Cloak, Ernst, Fujii, Hedemark, and Chang (2009), using DTI, 
found that, compared to age-matched controls, prenatally MA-exposed children had lower 
diffusion in frontal and parietal white matter tracts (as measured by the apparent diffusion 
coefficient). Although the exact mechanism of how PME may lead to lower brain diffusivity 
is unknown, lower white matter diffusivity typically reflects, among other outcomes, more 
compact axonal fibers. Reduced myelination and higher dendritic density have also been 
reported in rat pups prenatally exposed to MA (Melo, Moreno, Vázquez, Pinazo-Durán, & 
Tavares, 2006).  
The findings of lower diffusivity in frontal and temporal white matter are consistent 
with those of two MRS studies (Chang et al., 2009; Smith et al., 2001). Smith et al. (2001) 
found elevated levels of creatine (Cr) in the striatum in children with a history of prenatal 
MA exposure. Chang et al. (2009), using a much larger sample, found higher metabolite 
concentrations of total Cr, as well as of N-acetyle (NA), and of glutamate and glutamine 
(GLX), in the frontal white matter and thalamus. Because the three metabolites NA, Cr, and 
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GLX are present in neurons, their higher white-matter concentrations suggest increased 
axonal density or compactness in MA-exposed children (as confirmed by the DTI results 
presented by Cloak et al. (2009)).  
As with the sMRI findings, an etiology for the increased metabolite concentrations in 
children with PME is not clear. It is possible that the higher metabolite levels suggest 
accelerated growth patterns in these children. Previous MRS studies of normally developing 
children (Kreis, Ernst, & Ross, 1993), and of healthy mice (Weiss, Melkus, Jakob, & Faber, 
2009), found age-dependent increases in total CR, NA, and GLX, similar to the levels 
observed in the MRS studies discussed above. Alternatively, it is possible that the known 
vasoconstrictive effects of PME could result in altered cell energy metabolism in exposed 
children (Golub et al., 2005; Won et al., 2001). 
Functional neuroimaging findings. Again, this is a small body of literature, 
featuring only two published studies (see Table 2). Those studies do, however, report results 
that one might interpret as being broadly consistent with those from sMRI and animal studies: 
They also identify limbic and striatal regions as being particularly vulnerable to the effects of 
PME. 
In a design similar to that of Sowell et al.‟s (2010) sMRI study, Lu et al. (2009) 
compared functional activation in response to a verbal memory task in three groups of 
children: those with prenatal exposure to both MA and alcohol, those with prenatal exposure 
to alcohol alone, and age-matched non-exposed controls. Although both exposure groups 
showed similarly impaired performance on the memory tasks, children with PME recruited 
more diffuse areas in the bilateral medial temporal lobes than the alcohol-exposed and control 
groups. The authors interpreted these findings as suggesting that children with PME may 
need to allocate additional (and more diffuse) resources to achieve the same level of medial 
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↓activation in right caudate and putamen 
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Note. Only significant results are included in the table. PME+ALC = prenatal methamphetamine exposure with 
concomitant alcohol exposure; ALC = alcohol; HC = healthy controls. 
 
The other published fMRI study in this area of research (again, using the same study 
design as the one described above) found more severe functional alterations in children with 
prenatal MA and concomitant alcohol exposure than those with alcohol exposure alone, 
compared to age-matched non-exposed controls (Roussotte et al., 2011). Specifically, 
decreased activation was observed in several fronto-striatal circuits in children with prenatal 
MA+alcohol exposure as they completed a visuospatial working memory task, relative to the 
control group. This finding is consistent with the evidence of structural and metabolic 
abnormalities of the striatum and fronto-striatal connections, discussed in the previous 
section of this review (i.e., Chang et al., 2004, 2009; Roos et al., 2014; Smith et al., 2001). 
However, Roussotte et al., instead of observing the hypothesized negative correlations 
between activation in the caudate nucleus (implicated in working memory) and task accuracy, 
observed no correlation between cognitive performance and caudate activation. Unexpectedly, 
their statistical analyses revealed a negative correlation between task accuracy and activation 
in the putamen, bilaterally, in the prenatal MA+alcohol exposed group. 
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One possible interpretation for this finding may be offered by way of understanding 
the potential interactions between the basal ganglia-thalamocortical circuits and their regional 
connections. Each circuit is organized in parallel and underlies specific motor, cognitive, or 
affective functions (Cummings, 1993; Middleton & Strick, 2000). For example, the 
dorsolateral prefrontal loop (implicated in working memory) engages the dorsolateral caudate 
(Lewis, Dove, Robbins, Barker, & Owen, 2004), whereas the putamen is involved in the 
motor loop (Seger, 2009). Because striatal dopamine depletion (such as that observed in rat 
studies on PME; e.g., Bubenikova-Valesova et al. (2008)) appears to result in changes in 
cortico-striatal network properties, it is possible that this depletion may lead to a remapping 
of cerebral connectivity (in particular, reduced spatial segregation) and may ultimately result 
in increased interaction between the different cortico-striatal loops (Helmich et al., 2010).  
Similar patterns of data occur in patients with Parkinson‟s disease, which features 
reduced levels of striatal DA (Morrow, Roth, Redmond, & Elsworth, 2011). Therefore, it is 
possible that a mechanism similar to the one occurring in Parkinson‟s disease may occur in 
children with PME. That is to say, damage to DA terminals in the striatum during ontogeny 
may affect the development of neural circuits and lead to a comparable remapping 
phenomenon, as suggested by Cadet and Krasnova (2009). Thus, in children with PME, it is 
possible that the dorsolateral prefrontal loop (activated during working memory tasks) may 
engage the putamen (rather than the dorsolateral caudate), due to reduced spatial 
discrimination between the motor and dorsolateral prefrontal loops (Roussotte et al., 2011). 
Because the body of research described above is small, the postulated explanations for 
the effects observed and described in the reviewed studies are largely speculative, with little 
supporting evidence. Moreover, although the functional connectivity data reveal specific 
task-related changes in blood oxygen level-dependent (BOLD) response in prenatally MA-




modulation. The recent discovery of regions that are  consistently more active during resting 
periods than during cognitive demand (see Fox & Greicius, 2010; Greicius, Krasnow, Reiss, 
& Menon, 2003) suggests scope for examining resting state data in those with PME. 
However, to date there are no published data on resting state connectivity in prenatally MA-
exposed individuals, and only one study (Ahmadlou, Ahmadi, Rezazade, & Azad-Marzabadi, 
2013) has examined global organization of functional brain connectivity in adult MA users. 
Resting-state neuroimaging. Resting-state fMRI (RS-fMRI) is a relatively novel 
technique that offers potential for exploring PME-associated abnormalities in functional 
connectivity. In RS-fMRI, the neurophysiological index is the BOLD signal, which exhibits 
low-frequency spontaneous fluctuation in the brain at rest (i.e., no task is performed during 
the scan – rather, the participant is instructed to remain still with eyes closed or open; 
Greicius, 2008). Numerous studies have suggested that variations in BOLD signal, 
temporally correlated across the brain, are of neuronal origin and correspond to functional 
resting-state networks (RSNs; Beckmann, DeLuca, Devlin, & Smith, 2005; Damoiseaux et al., 
2006; Fox & Raichle, 2007). Together, these RSNs characterize the neuronal baseline activity 
of the human brain in absence of task-based or externally stimulated neuronal activity, and 
may reflect functionally distinct networks. 
The last 15 years have witnessed a steady increase in the number of RS-fMRI studies 
(Cole, Smith, & Beckmann, 2010). The growing popularity of RS-fMRI can be ascribed to 
several factors: (1) It provides a measure of the intrinsic connectivity of neural networks that 
is highly reliable across both subjects (including children) and scans (Shehzad et al., 2009; 
Thomason et al., 2011; Van Dijk et al., 2010); (2) its minimal task demands and scanner time 
(a full dataset can be collected in as little as 5 minutes) encourage compliance in difficult-to-
scan populations, such as children, without the need for sedation; and (3) it is sensitive to 
brain abnormalities across a range of clinical disorders (Rosazza & Minati, 2011). Thus, RS-
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fMRI provides an opportunity to offer new insights on the effects of PME on brain activity, 
as well as the relationship between RSNs and the cognitive and behavioral outcomes that 
have been described in affected individuals. 
Structure-function correlations. The studies reviewed thus far present evidence of 
structural and functional deficits, and of clinical cognitive and behavioral phenotypes, in 
PME. While such research contributes to our knowledge of the seemingly multifaceted 
manifestations of PME, correlational analyses investigating brain-behavior relationships 
provide opportunity for a clearer understanding of the neurobehavioral and neuroanatomical 
tenets that underlie developmental outcomes in PME. Among the studies described in the 
section headed Structural and Metabolic Neuroimaging Studies, three have reported 
correlations between structural or metabolic brain abnormalities and neurocognitive 
performance in children with PME. 
Chang et al. (2004) found that the smaller size of the putamen and globus pallidus in 
children with PME was associated with relatively impaired performance on a task of 
sustained attention. In the same study, reduced hippocampal volume was also associated with 
relatively impaired performance on a verbal memory task. These correlations of performance 
on attention and memory tasks with volumetric reductions in subcortical structures are also 
consistent with reports linking smaller striatal brain volume (and deficits in the dopaminergic 
system) with impaired learning in children with PME (Thompson, Levitt, & Stanwood, 2009). 
In the second correlational study, investigating potential interactional effects of 
prenatal MA and alcohol exposure on cognitive outcomes, Sowell et al. (2010) found 
volumetric reductions in striatal and thalamic regions for both prenatal MA+alcohol and 
prenatal alcohol-only groups, compared to controls. For the prenatal MA+alcohol group, 
reduced volumes in the caudate nucleus (a structure associated with mental processes such as 
memory, learning, motor control, and punishment and reward) were negatively correlated 
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with IQ. This effect was not observed in the alcohol-only group, suggesting that children with 
prenatal methamphetamine and alcohol exposure may have more severe cognitive deficits 
than those exposed to alcohol alone. Given the prevalence of concomitant alcohol exposure 
in PME research, as indicated by several of the studies reviewed here (Lu et al., 2009; 
Roussotte et al., 2011), such findings warrant further replication.  
In terms of metabolic correlates, one MRS study (Chang et al., 2009) found that 
decreased metabolic activity in the frontal white matter and thalamic regions was correlated 
with poor performance on tasks assessing visuomotor integration. Consistent with some of 
the behavioral findings presented in previous human research (e.g., Chang et al., 2004), as 
well as in animal studies (Šlamberová, Pometlová, & Charousová, 2006), it is possible that 
PME results in altered psychomotor development via changes to the dopaminergic system in 
fronto-striatal or thalamocortical pathways.  
Challenges in Prenatal Drug Exposure Research 
All the studies reviewed thus far have been subject to numerous ethical and 
methodological restrictions. Regarding research ethics, views on what constitutes an 
appropriate response to drug-exposed infants vary due to the many complex issues endemic 
to perinatal substance use. For example, reporting pregnant illicit drug users to child welfare 
authorities is often argued to be an ethical obligation; however, research shows that pregnant 
women who fear prosecution and loss of custody as a result of their drug use are less likely to 
seek help or essential prenatal care (Poland, Dombrowski, Ager, & Sokol, 1993; Roberts & 
Nuru-Jeter, 2010). Although the scope of this review does not cover the aforementioned 
complexities, an appropriate response in terms of research on prenatal drug exposure and 
social policy is an important consideration, and I refer the reader elsewhere (see Lester, 
35 
Andreozzi, & Appiah, 2004; Ondersma, Simpson, Brestan, & Ward, 2000; Thompson et al., 
2009). My focus here, instead, is on methodological constraints pertinent to research on PME.
From a methodological perspective, research on the effects of PME is problematic 
and has, to date, been limited. One challenging aspect is that prevalence statistics are difficult 
to establish and often fluctuate from site to site. Variations in prevalence rates may be 
attributed to differing sampling and drug detection methods (e.g., immunoassay vs. 
meconium testing), screening women in different settings (e.g., community samples vs. 
targeted samples, such as drug rehabilitation centers or prisons), and obtaining data at various 
points in time (Behnke et al., 2013). For example, many of the existing PME studies feature 
retrospective designs, and thus data pertaining to the quantity, frequency, and combinations 
of drugs used, and at what points they were used during pregnancy, is often inaccurate or 
unavailable (Kaltenbach & Finnegan, 1993; Maisto, McKay, & Connors, 1990). 
In direct relation to the challenges outlined above, a frequently cited limitation of 
PME research is that documentation of MA use by women during pregnancy is typically 
based on self-report measures, without verification by toxicological analysis. Moreover, 
information from the primary source is often inaccessible. This is because many child 
participants in PME studies have been removed from the custody of their biological mothers 
due to the presence of drugs, violence, and neglect in the home (Smith, Johnson, Pears, 
Fisher, & De Garmo, 2007). Therefore, information regarding the mother‟s substance use 
history is often collected by way of medical and legal records, and/or reports from adoptive 
or foster parents. Consequently, establishing whether there is a dose-response curve in terms 
of neurocircuitry and behavioral outcomes, and the shape of that curve, is problematic.  
The issue of accuracy of maternal drug exposure histories is further compounded by 
the prevalence of polysubstance abuse. Children with PME are at high risk of in utero 




(Smith et al., 2006). Abuse of each of these substances has its own particular consequences 
for brain structure and function (Salisbury, Ponder, Padbury, & Lester, 2009; Smith et al., 
2006; Sowell et al., 2010). Hence, in polysubstance abusing mothers, it is difficult to tease 
apart the effects of MA from that of (an)other drug(s). One way of resolving the confounding 
effects of polydrug abuse in PME research might be to recruit samples without concurrent 
polydrug exposure; however, such samples are rare. Therefore, research on children with 
PME might be more ecologically valid if, in fact, one did not try to recruit those with “pure” 
exposure to MA alone. A more viable solution, then, might be to recruit larger samples in 
order to isolate the effects of a specific drug. With a large enough sample size, there may be 
enough statistical power and variability among various combinations of drugs to be able to 
covary or adjust the effects of the drug of interest for the effects of other drugs. 
 
Summary and Conclusion 
I have summarised findings from the cognitive, affective and neuroimaging literature 
in infants and children exposed to MA prenatally. I have also discussed, using findings from 
animal studies, some of the underlying neuroteratogenic mechanisms of PME. 
The teratogenic effects of PME appear likely to result from interference with the 
neurotropic roles of monoaminergic transmitters (particularly DA) during brain development 
(Frost & Cadet, 2000). This interference with the DA system is, in turn, postulated to have a 
significant effect on cortical neuronal development, and may lead to morphologic deviations 
in several brain structures (particularly the striatum and several limbic structures). Overall, 
there are too few published neuroimaging studies on the effects of PME in humans to draw 
any definitive conclusions regarding the brain systems most affected by PME. However, 
despite the limited evidence, diverse methodology, and small sample sizes, some consistent 
patterns of abnormalities have emerged: It appears that the development of areas of the brain 
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responsible for the regulation of attention, memory, visual-motor integration, and executive 
functioning are particularly vulnerable to PME. The striatum, specifically, seems to be 
susceptible to structural and metabolic alterations as a result of PME (Chang et al., 2004; 
Smith et al., 2001).  
Recently, the IDEAL study has begun systematic documentation of some of these 
functional and behavioral deficits in infants with PME. Findings include poor movement 
quality, decreased arousal, increased stress, and attention difficulties (LaGasse et al., 2011). 
Support for the clinical significance of these abnormalities is also beginning to surface: There 
are suggestions that PME may have significant neurocognitive effects even beyond that of 
frequently co-occurring alcohol exposure (Sowell et al., 2010). Unfortunately, long-term 
developmental data for older controlled cohorts is scarce; however, existing research suggests 
that children with PME may be more vulnerable to disorders of executive function, 
manifested by externalizing behavioral problems and aggression (Diaz et al., 2014; LaGasse 
2012).  
In conclusion, study of the effects of PME is still evolving and further investigation is 
needed to confirm existing findings. The reviewed literature suggests that children exposed to 
MA in utero may experience a range of neurotransmitter and neurostructural alterations, with 
potential long-term cognitive and behavioral sequelae. Currently, we do not know how data 
from different imaging modalities relate to each other in this literature, and we know little 
about how imaging findings correspond to child affective, behavioral, and cognitive 
functioning. 
Rationale, Specific Aims, and Hypotheses 
An extensive literature search yielded no evidence of published South African 
research that has examined functional and neurobiological imaging data alongside 
38 
neurocognitive profiles in children exposed to MA in utero. Moreover, globally, there are few 
studies that have examined resting state connectivity specifically in pediatric populations in 
low and middle-income countries.  
The proposed study is nested within an ongoing prospective longitudinal cohort study 
investigating the structural and cognitive correlates of prenatally MA-exposed children in 
Cape Town. The aim of this larger study is to investigate: (1) whether cognitive functioning 
is impaired in children with a history of PME and, if it is, (2) whether there are any 
significant correlations with impairments/defects, detected via sMRI, DTI, and MRS, in the 
associated areas. 
Given the known impact of MA exposure on striatal structures in adult users, and 
limited evidence for the same in children, the design of the current study allowed for the 
exploratory testing of these specific hypotheses:  
1. Children with a history of PME will show impaired performance on measures of IQ,
memory, language, and visual-motor integration and co-ordination when compared to 
typically developing, demographically-matched controls.  
2. Deficits in IQ, memory, language, and visual-motor integration and co-ordination
will be related to the effects of PME and not to the effects of potential confounding variables, 
such as prenatal alcohol exposure and maternal level of education. 
3. Children with a history of PME will show disrupted functional intrinsic
connectivity in frontal cortical, visuomotor and striatal networks when compared to typically 





Design and Setting 
The study featured a cross-sectional quasi-experimental case-control design. As noted 
earlier, this study forms part of a larger prospective longitudinal research programme. The 
aim of that programme is to investigate the effects of PME on neurodevelopment and 
cognition by gathering, across several testing occasions stretching over several years, 
neuropsychological and neuroimaging data from the same cohort of children with PME.  
 
Participants  
The sample comprised 45 children, between the ages of 6 and 7 years. Participants 
were assigned to either the PME group (n = 23; 10 boys, 13 girls) or the control group (n = 
22; 10 boys, 12 girls).  
Recruitment and eligibility criteria. Mothers of the 45 children included in this 
study were recruited by means of telephonic interviews, with assistance from the local school 
and care center, and resident social worker. The PME group comprised children whose 
mothers had disclosed that they had used MA during pregnancy. The control group was 
aggregate matched to the PME group on the following variables: age, sex, background, birth 
circumstances, gestation, and schooling. Both the PME and control groups comprised 
children who were born to women residing in a low socioeconomic status (SES), 
predominantly Cape Coloured (i.e., mixed ancestry) area of Cape Town. 
Participants were excluded from the study if they, in the past or at the time of the 
assessment, had a pathology that might have influenced their neurocognitive functioning. 
These pathologies included: prematurity (i.e., a gestational age of less than 36 weeks); severe 
cases of neonatal jaundice, bacterial meningitis, or hypoglycemia; head injury; pre- or 




with known associated developmental delay. Because the parent study contained a 
neuroimaging component, participants with a declared presence of implanted metal in the 
body were also excluded. 
In view of the limitations of research based on prenatal polysubstance exposure, 
participants whose birth mothers admitted to regularly abusing recreational drugs other than 
MA (e.g., cannabis, cocaine, opiates) during pregnancy were excluded from the study.  
 
Measures 
Although the standardized measures included in this study have been widely used in 
South African clinical research and practice, most of them have few or no published South 
African norms. This lack of locally appropriate normative data did not affect the aims, design, 
or power of the project, because performance for participants with a history of PME was 
compared to that of non-exposed control participants, and not to published normative data. 
All tests were administered to participants in the language of instruction used at 
school (viz., either English or Afrikaans). Where standardized Afrikaans test instructions 
were not available, the original English instructions were translated by an first-language 
Afrikaans-speaking Clinical Psychology Master‟s student and checked by a bilingual 
(English and Afrikaans) doctoral-level neuroscientist at the Cape Universities Brain Imaging 
Centre (CUBIC) with extensive experience of the children in this cohort. Table 3 summarizes 
the cognitive domains assessed by each neuropsychological measure. 
Sociodemographic questionnaire. This 41-item instrument (see Appendix A), 
created specifically for the larger study within which this one is nested, includes questions 
pertaining to various demographic variables (e.g., participant‟s and parent‟s age, sex, health 
history, home language, and educational attainment). The last section of the questionnaire 
includes items pertaining to the participant‟s birth details (such as gestation period and birth 
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weight), current anthropometrics (weight, height, head circumference, etc.), and medical 
history. 
Table 3 
Cognitive Outcome Variables 
Domain / Variables Definition 
KABC-II General Intellectual Functioning 
Non-Verbal Index Non-verbal IQ derived from performance of 5 subtests 
Hand Movements Total correctly copied hand sequences 
Block Countinga Total correctly counted block sequences 
Conceptual Thinkingb Total correctly identified pictures 
Triangles Total correctly constructed geometrical shapes 
Story Completion Total correctly completed picture sequences 
Pattern Reasoning Total correctly identified pattern sequences 
KABC-II Learning Ability 
Atlantisc Number of correctly identified items on immediate recall trial 
Atlantis Delayedc Number of correctly identified items on the delayed recall trial 
Language 
BNT-SA-SF Total number of correctly named items 
Visuospatial and Psychomotor Ability 
Beery VMI Total correctly copied designs 
Visual perception Total correctly matched designs 
 Motor Coordination 
Grooved Pegboard Test 
Total correctly drawn designs 
Insertion times DH Total correctly inserted pegs (dominant hand) 
Insertion times NDH Total correctly inserted pegs (non-dominant hand) 
Drops DH Total drops (dominant hand) 
Drops NDH Total drops (non-dominant hand) 
Note. KABC-II = Kaufman Assessment Battery for Children (Second Edition); BNT-SA-SF = Boston 
Naming Test (South African Short Form); Beery VMI = Beery Test of Visual-Motor Integration; DH 
= dominant hand; NDH = non-dominant hand. 
aOnly 6-year-olds completed the Conceptual Thinking subtest for the KABC-II NVI.  
bOnly 7-year-olds completed the Block Counting subtest for the KABC-II NVI.  
cThe KABC-II Atlantis and Atlantis Delayed subtests were added to the battery as a means to assess 
learning and memory. These subtests are not part of the KABC-II NVI. 
Drug intake questionnaire. This 24-item questionnaire (see Appendix B), created 
specifically for the larger study within which this one is nested, assesses the duration, 
frequency, and severity of MA use by mothers during pregnancy. It also screens for use of 
alcohol, cigarettes, and other recreational drugs during pregnancy. 
The Beery Developmental Test of Visual-Motor Integration. The Beery VMI (4th 
edition; Beery, 1997) is a 27-item paper-and-pencil test designed to assess the extent to which 
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children aged 2 years and older are able to integrate their visual and motor abilities. The 
participant is asked to copy 27 geometrical designs as accurately as possible. The designs 
range in complexity from very simple (e.g., a straight line) to quite complicated (e.g., cubes, 
overlapping circles). The VMI also includes two supplemental tests (each featuring as stimuli 
the same 27 geometric forms as the main test) that are used to assess, respectively, aspects of 
visual perception and motor coordination. The Visual Perception Test requires the child to 
identify, from a selection of similarly-shaped targets, the exact match for each of 27 
geometric forms. The Motor Coordination Test requires the child to trace the stimulus forms, 
using a pencil, without going outside double-lined paths. 
Although cross-cultural validity for the Beery VMI has not yet been established, the 
test is, on the face of it, virtually culture-free, utilizing geometric shapes instead of letters and 
numbers. The test does have strong content, concurrent, and predictive validity, however 
(Beery, 2004). An average of Anastasi‟s (1988) three major reliability error sources (inter-
scorer, internal consistency, and test-retest) indicated overall reliability estimates of .92 
(VMI), .91 (Visual Perception), and .90 (Motor Coordination; Beery, 2004). Furthermore, 
there are no statistically significant effects of sex, ethnicity, socioeconomic status, and place 
of residence (urban versus rural) on test performance (Brown & Rodger, 2008). 
Kaufman Assessment Battery for Children - Second Edition. The KABC-II 
(Kaufman, 2004), designed for use in children and adolescents between the ages of 3 and 18 
years, yields an IQ measure that reflects overall processing and cognitive abilities. It is 
divided into three levels: subtests appropriate for children aged 3, aged 4-6, and aged 7-18. 
The set of KABC-II subtests used here were, with one exception, those that constitute 
the instrument‟s Nonverbal Scale (NVS). The NVS permits valid assessment of children who 
have limited English proficiency, and is comprised of only those subtests that can be 




cognitive domains in children aged 4-18: sequential processing, simultaneous processing, and 
planning ability. The sum of performance across the different subtests/domains within the 
NVS yields a global functioning score, the Nonverbal Index (NVI). 
The NVS is fairly stable; the developers report average test-retest coefficients of .72 
and .87 for the NVI at ages 3-6 and 7-18, respectively. Internal consistency coefficients for 
the NVI are reported as .90 and .92 at ages 3-6 and 7-18, respectively. Construct validity of 
the KABC-II is supported by factor-analytic studies described in the test manual (Kaufman, 
2004). In South Africa, the KABC-II appears in a survey of instruments utilized by South 
African psychologists (Foxcroft, Paterson, Le Roux, & Herbst, 2004). Although there are no 
published local normative data for the KABC-II, it remains one of the less culturally loaded 
IQ tests available (Greenop, Fry, & de Sousa, 2012). Below, I give basic information about 
each KABC-II subtest used in the current research. 
Hand Movements. This subtest allows for the assessment of sequential processing 
and short-term memory solely in the visual-motor channel. The child is requested to copy the 
examiner‟s precise sequence of taps on a table with the fist, palm, or side of the hand.  
Block Counting. This subtest provides a measure of both simultaneous and visual 
processing with regard to spatial relationships, and it assesses conceptualization as well as 
visualization. The child counts the exact number of blocks in pictures of stacks of blocks that 
are configured so one or more of the blocks is partially or completely hidden from view.  
Conceptual Thinking. This subtest assesses classification and induction abilities. The 
child is presented with a set of four pictures, and is asked to identify the one that does not 
belong in the set. Some items in the pictures are meaningful stimuli, while others are more 
abstract.  
Triangles. This subtest assesses spatial relations and visualization. The child is first 




by the examiner. Then, for the more challenging items, the child is given two or more foam 
triangles (colored blue on one side, and yellow on the other) and asked to assemble them to 
match a picture of an abstract design.  
Pattern Reasoning. This subtest requires the manipulation of abstract designs and 
symbols, thus assessing induction and visualization abilities. The child is presented with a 
series of stimuli (either abstract or meaningful) that form a logical, linear pattern, with one 
stimulus missing. The child is then required to complete the pattern by selecting the correct 
stimulus from a range of four to six options.  
Story Completion. This subtest assesses induction, visualization, and general 
sequential reasoning by asking the child to sequence pictures in a logical, narrative order. The 
child is shown a booklet with a set of pictures that tell a story; however, one to three pictures 
are missing. A set of pictures is then given to the child, from which only the ones that are 
needed to complete the story must be selected and placed in the correct locations. 
The KABC-II subtests listed above are those that constitute the NVS. To assess 
memory and learning ability, the KABC-II Atlantis and Atlantis Delayed subtests were added 
to the current battery. 
Atlantis. This subtest is designed to measure a child‟s ability to learn new information 
(through associative memory) using colorful, interesting stimuli. The examiner teaches the 
child a set of nonsense names for pictures of four fish, four plants, and four shells. The child 
is then asked to point to the specified picture (out of an array of similar or previously 
presented targets) when it is named. During the assessment, the examiner provides feedback 
each time the child makes an error, as each picture has no symbolic relationship to its paired 
nonsense word. Because the subtest provides no context for learning cues, the feedback for 




Atlantis Delayed. This subtest is administered 15-25 minutes after Atlantis, and the 
child is not forewarned that it is coming. The child demonstrates delayed recall of paired 
associations made earlier by pointing to a picture of the fish, plant, or shell that is named by 
the examiner. This subtest assesses the ability to retrieve newly encoded information after a 
filled delay. 
Boston Naming Test (South African Short Form). The BNT-SA-SF is a test of 
confrontation naming ability, based on the original 60-item BNT (Kaplan, Goodglass, & 
Weintraub, 1983, 2001). The BNT-SA-SF consists of 15 black-and-white drawings that are 
presented in order of increasing difficulty, ranging from simple everyday objects (e.g., comb) 
to less familiar objects (e.g., sphinx). Upon presentation of the stimulus, participants are 
given 20 seconds to produce a spontaneous response, after which a semantic cue (e.g., „it is 
used on hair‟ for comb) is given.  If the participant is still unable to answer, a phonemic cue is 
offered (e.g., „it starts with the sound |ko|‟). After the full test is administered, the examiner 
returns to the items that were failed, and asks the participant to select a correct answer from 
four multiple-choice options that are read aloud. 
A recent study of the BNT-SA-SF‟s psychometric properties found good test-retest 
reliability (Spearman‟s r = .39, p = .033), and good correlation with the full 60-item test 
(Spearman‟s r = .54, p = .002; Baerecke, 2010). 
Grooved Pegboard Test. The GPT (Trites, 1977) is a manipulative dexterity test that 
is used to assess complex visual-motor coordination. The equipment consists of a pegboard 
with 25 holes, with randomly positioned slots. Pegs with a key on one side must be rotated to 
match the slot at a hole before they can be inserted. Participants are instructed to place all 
pegs into the 25 holes, picking up one at a time, and using just one hand (dominant hand first, 
and then non-dominant hand). The examiner records time of completion for the first line, 




The GPT‟s validity and reliability are well established through generous research in 
both healthy and patient populations (see, e.g., Maj et al., 1993; Ruff & Parker, 1993). For 
instance, it has good test-retest reliability (.91 and .85 for right and left hands, respectively; 
Wang et al., 2011). Cross-cultural validity for the GPT has been verified for South African 
children and adolescents, with no significant between-race, -language, or -sex differences 
(Ferrett et al., 2014).  
 
Procedure 
The research assistant (RA) at CUBIC carried out the recruitment, screening, data 
gathering, and data capturing for Phase I of the study (described below). Similarly, the 
imaging team at CUBIC was responsible for all scanning procedures (described below under 
the heading Image Acquisition). I was responsible for all the procedures outlined in Phase II 
of the study (described below).  
Phase I. The RA contacted each potential participant‟s parent/caregiver 
telephonically, informed him/her about the study, and screened the participant according to 
the eligibility criteria outlined previously. Upon verbal agreement and expressed willingness 
to participate in the study, the RA scheduled an appointment for each individual participant 
and his/her caregiver. 
On arrival at CUBIC, the RA reintroduced the parent to the study, explained the 
purpose of the study, and obtained verbal assent (from the child) and written consent (from 
the parent). The parent also provided a detailed demographic, medical and socio-economic 
history. In cases where the birth mother was absent or unable to attend, collateral information 
was gathered from the family member(s) present (n = 19), and followed up with a telephonic 
interview with the mother (where possible). Anthropometrics (including weight, height, and 




recruited into this study were no longer living with their biological mother, the term „mother‟ 
and „parent‟ (used interchangeably) will, from here onwards, denote both caregiver and/or 
biological mother. 
 After the interview with the mother, participants were accompanied to a separate 
room to prepare, using a mock scanner, for image acquisition. Due to the loudness of the 
scanner and anticipated anxiety of the child in scanning situations (Malisza, Martin, Shiloff, 
& Yu, 2010), the RA was trained to familiarize the participant with the procedure. The scan 
process was simulated to encourage minimal distress and movement – this entailed a 
demonstration of positioning in the mock scanner, as well as familiarization with the audio 
environment via prerecorded sound snippets. 
As no functional tasks were administered during the scan, each participant was 
provided with the option of selecting an animated movie (visible through a head-coil-
mounted mirror) which was played after the completion of the resting state sequence. Parents 
were asked to sit alongside their children throughout the scan.  
Image acquisition. Resting-state fMRI (RS-fMRI) echo planar imaging (EPI) data 
were acquired for 6 minutes from a 3T Allegra Siemens scanner (MAGNETOM Allegra, 
Erlangen, Germany) at CUBIC (slice thickness 4 mm; TR 2000 ms; TE 30 ms; voxel size: 
3.4×3.4×4.0 mm). Participants were asked to close their eyes and relax during the resting 
state sequence. A high resolution motion-navigated T1 multiecho magnetization-prepared 
rapid acquisition with gradient echo (MP-RAGE) structural scan (repetition time of 2,530 ms; 
4 echo times of 1.5 ms, 3.2 ms, 4.8 ms and 6.5 ms; flip angle of 7°; matrix size of 
224×224×144; field of view of 224 mm; voxel size of 1.3×1.0×1.0 mm) was then acquired 
for anatomical localization. Other scan sequences, including DTI and MRS, were also 
obtained. Analyses of data from those sequences are not reported here. Total scan time was 
approximately 35 minutes. 
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Phase II. Within 8-20 weeks of the scan, I contacted each participant‟s parent 
telephonically and scheduled an appointment for a cognitive assessment at Red Cross 
Children‟s Hospital (RXH). Where possible, and to increase reliability of the data, I 
requested the presence of the birth mother so that an additional substance intake questionaire 
(described under Measures) could be administered.  
On the day of testing, I reminded the attending parent of the purpose of the study and 
of their child‟s role in it. In consideration of privacy and confidentiality, I accompanied the 
participant to a separate desk to watch a children‟s television show for the duration of the 
parent‟s interview. I then interviewed the parent using the timeline follow-back method, a 
valid and reliable means of gathering retrospective data on the duration, frequency, and 
severity of alcohol and drug exposure during pregnancy (Jacobson, Chiodo, Sokol, & 
Jacobson, 2002). Post-interview, I requested that the parent leave the room for the duration of 
the child‟s neurocognitive assessment. Snacks and refreshments were provided in the waiting 
area. 
Neurocognitive assessment. Prior to the commencement of the formal assessment, I 
talked each participant through the procedure and gave him/her information regarding its 
content, duration, and purpose (within reason; see Ethical Considerations section below) so 
as to ameliorate any distress or anxiety s/he may have experienced. I then gave the participant 
an opportunity to ask questions. I administered all instructions in the child‟s language of 
educational instruction (either English or Afrikaans). Two fairly recent South African studies 
suggest that even if the home language and the medium of instruction are not the same, the 
more reliable language for the individual to be tested in is that in which s/he has received 
formal education (Bethlehem, de Picciotto, & Watt, 2003; Shuttleworth-Edwards, Donnelly, 
Reid, & Radloff, 2004). 
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 To facilitate rapport building and familiarity, I administered the cognitive tests in the 
following order: Beery VMI, KABC-II subtests, BNT-SA-SF, and the GPT. The Beery VMI 
is straightforward and interactive, the KABC-II is more time-consuming and has a higher 
cognitive demand, and the BNT-SA-SF and GPT are both quick and fairly simple to 
complete. Depending on the individual needs and concentration span of the participant, I 
provided two to three breaks throughout the course of the assessment. Snacks and 
refreshments were also supplied during these breaks.  
Upon completion of testing, I escorted each participant to his/her parent, who was 
fully debriefed and thanked for cooperating and participating. Prior to leaving, I gave 
participants and their parents an opportunity to discuss any concerns or express opinions 
regarding the research experience. In cases where commentary on the participant‟s 
performance was requested, I arranged telephonic feedback sessions. 
Ethical Considerations 
This study adhered to the protocols and ethical guidelines for research as outlined by 
the Health Professionals Council of South Africa (HPCSA) and the University of Cape 
Town‟s (UCT) Codes for Research involving Human Subjects, as well as the guidelines 
contained in the Declaration of Helsinki (World Medical Association, 2008). Ethical approval 
for the parent study was granted by the Human Research Ethics Committee of UCT‟s Faculty 
of Health Sciences (Ref#: 235/2009; see Appendix C).  
Due to the stigma associated with MA use and exposure, and the young age of the 
participants, I only fully debriefed the parents of child participants as to the topic and purpose 
of the research. I told child participants that they were participating in a „brain study,‟ rather 
than a study on the effects of PME. Informed consent and assent were obtained as part of the 
parent study prior to commencement of Phase I (see Appendices D and E, respectively). I 
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informed children and their parents that their participation was entirely voluntary, and that 
they had the right to withdraw at any point during the study.  
To ensure confidentiality, all the imaging data collected at CUBIC was anonymized 
prior to analysis, and archived on a research-dedicated database at the Centre for High 
Performance Computing in Cape Town. No unauthorized access to study data was permitted. 
All the information and test results that were gathered during the interview and assessment, 
respectively, were kept strictly confidential. Furthermore, to ensure anonymity, I allocated 
each participant a code number under which all his/her data were stored.  
Parents were informed in the consent form, however, that parental consent may be 
requested for access to additional medical records and/or transfer of obtained data to a 
medical expert should such a need be identified. Thus, in instances where significant social, 
psychological, or learning problems were identified (which, in the current study, happened 
once), I notified the principal investigators of the larger study, and a referral to the relevant 
organization was made. 
There were no significant risks attached to participation in this study. In instances 
where participants experienced substantial distress or anxiety, as was occasionally the case 
during the MRI scan, the procedure was stopped. The parents and children who participated 
in this research incurred no financial costs pertaining to their involvement. In instances where 
the parent and/or child had to take leave from work/school to participate, I provided a letter to 
account for their absence. Transport to and from all appointments at both CUBIC and RXH 
was arranged and paid for by the parent study. Participants and their parents also received 
remuneration in the form of school supplies (to the value of ZAR80) and supermarket gift 




Data Management and Statistical Analyses 
Neuropsychological data preprocessing and analysis. Prior to any formal statistical 
analyses, I checked and cleaned the data. For the Beery VMI, KABC-II, BNT-SA-SF, and 
GPT, I followed standard scoring procedures as set out in the respective test administration 
manuals. With the exception of the BNT-SA-SF and GPT (where raw scores were converted 
to z-scores), age-adjusted scaled scores (with a mean of 10 and a standard deviation of 3) 
were used in the final analyses. I used SPSS version 22.0.0 to analyze the data. No missing 
data were identified for the cognitive outcome variables. In instances where outliers (i.e., 
scores falling more than 3 SD from the mean) were identified (n = 3), these data were 
inspected and thought to represent the true performance within the population of scores, and 
thus left unadjusted.  
The analysis began with an exploration of the data and testing of assumptions that 
underlie inferential statistical analyses. Unless otherwise stated in the Results section, all 
assumptions for the relevant analyses were upheld. In instances where data were not normally 
distributed, I employed non-parametric statistical measures. Then, to examine whether the 
PME and control groups were well matched on a specific set of sociodemographic variables, 
I used a series of one-tailed t-tests to compare scores on all continuous variables (i.e., age and 
mother‟s level of education), and a series of chi-square analyses to compare scores on all 
categorical variables (i.e., sex, language, grade, handedness). 
At the next data analytic step, independent sample t-tests (one-tailed), or, where 
appropriate, Mann-Whitney U tests (one-tailed), sought to detect between-group differences 
on the neurocognitive outcome variables. I used the Šídák multiple comparison correction 
(Abdi, 2007) to protect against inflated Type I error resulting from multiple pairwise 




relation between PME and each neurocognitive outcome variable was influenced by 
potentially confounding sociodemographic and anthropometric variables. 
For all analyses, the threshold for statistical significance (α) was set at .05. To allow 
for meaningful interpretations of significant results, I also reported an estimate of effect size 
(in this case, r), thresholded as follows: small (r = .10), medium (r = .30), large (r = .50), and 
very large (r = .70; Rosenthal, 1996). 
fMRI data preprocessing and analysis. RS-fMRI BOLD data were preprocessed 
and analyzed using the Analysis of Functional Neuroimaging (AFNI) toolkit 
(http://afni.nimh.nih.gov/; Cox, 1996) and tools from the Functional MRI of the Brain 
(fMRIb) Software Library (FSL; Smith et al., 2004; Woolrich et al., 2009). 
Preprocessing. Figure 2 is a flow diagram outlining each of the preprocessing steps. 
The first 4 volumes of the EPI were removed to account for magnetic inhomogeneity effects. 
The EPIs were placed into standard space through application of a warping matrix generated 
by the linear registration of the T1 dataset into Talairach space, using the template for 4.5 – 
8.5 year olds provided by the McConnell Brain Imaging Centre (Fonov et al., 2011). To 
minimize spatial smoothing, motion parameters (generated from aligning each volume of the 
EPI time series to the last volume), the warping matrix (generated from transforming the T1 
into Talairach space), and the EPI to T1 co-registration matrix were simultaneously applied 
to the BOLD. EPI voxels were then resampled to 3mm isotropic, and spatially blurred using a 
6mm full width at half maximum (FWHM) Gaussian kernel. A bandpass filter was applied to 






Figure 2. Schematic of RS-fMRI preprocessing pipeline – sequence and AFNI tools employed for 
each of the preprocessing steps. 
 
Independent components analysis (ICA). A probabilistic group-level ICA 
(Beckmann & Smith, 2004) was then implemented in MELODIC (Multivariate Exploratory 
Linear Decomposition into Independent Components), part of FSL (see Figure 3 for a 
schematic of ICA of fMRI data). The ICA is a statistical technique that separates a set of 
signals into independent spatiotemporal components (Beckmann & Smith, 2004). Currently, 
there is little consensus on how to select the optimal number of components; however, 
methods to do so have been proposed (i.e., Calhoun et al., 2001; Li, Adali, & Calhoun, 2007).  
The number of components identified by the ICA was set to 20, 25 and 35, in keeping 
with the typical dimensionality of resting-state ICA studies reported in the literature. After 
visual inspection of the resulting networks by MK and JI, the output of the 35-network ICA 
was selected for further group comparisons, based on the correspondence of the networks 
with canonical networks reported in the literature (Beckmann et al., 2005; Smith et al., 2009). 
The melodic ICA applies a high-pass filter setting of 100 sec (full width at half maximum) 
which was used to reduce very-low frequency artifact such as scanner drift. 
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Figure 3. Schematic of independent components analysis of fMRI data. In A, individual fMRI data 
sets are temporally concatenated. The ICA then combines these and converts them into a new data set 
comprising group time courses (B) and group spatial maps (C) for all the components. The RSNs are 
selected from the group spatial maps. Reproduced from Beckmann, Mackay, Filippini, and Smith, 
2009. 
The BOLD from each of the 26 participants was temporally concatenated, with 
variance normalization applied to the BOLD, prior to extracting 35 spatially orthogonal 
networks for the entire sample. The group spatial maps for these RSNs were then utilized as 
input for the dual regression, as outlined below. 
Dual regression analysis. The order of the spatiotemporal components extracted 
using ICA is arbitrary. To conduct comparisons between networks for the PME and control 
participants, it was therefore necessary to identify networks at the individual-subject level 
that corresponded to those extracted from the group ICA. This identification was achieved for 
this dataset using the dual regression methodology (Beckmann et al., 2005). FSL was used to 
carry out this step in a two-stage process. At the first stage, group-level components were 
regressed against the BOLD for each participant to identify corresponding subject-level time 
courses for each of the group ICA components (Cole et al., 2010). At the second stage, time 
courses from stage one were subsequently regressed once again from each participant’s 
BOLD, to identify spatial maps for each participant that corresponded to the group-level 




Between-group comparisons. The randomize tool in FSL was then used to perform 
comparisons between the control group and the PME group for all RSNs of interest (Winkler, 
Ridgway, Webster, Smith  & Nichols, 2014). This analysis used the spatial map images 
produced in stage two of the dual regression analysis to identify areas in the brain where the 
measure of RSN integrity was greater/weaker in the control group than in the PME group. To 
specify the desired comparisons, a general linear model (GLM) was incorporated into the 
randomize instruction by means of a design matrix specifying these particular contrasts: A > 
B (areas in which the PME group showed greater network integrity than the control group) 
and B > A (areas in which the control group showed greater network integrity than the PME 
group). Both of these contrasts adjusted for the average motion per participant, as well as the 
mean network Z scores, as specified in the design matrix. The null distribution was simulated 
for each contrast by means of Monte Carlo estimation, using 5000 permutations (Bellec, 
Rosa-Neto, Lyttelton, Benali, & Evans, 2010).  
 
Results 
Child Sample Characteristics 
Table 4 presents the sociodemographic and anthropometric information for the two 
groups, as well as maternal sample characteristics. For all continuous data, I used Levene‟s 
test to assess homogeneity of variance across the two groups, and examined the residual plots 
to check for departures from normality. Unless otherwise indicated, the assumptions of 
normality and homogeneity were upheld for all data distributions. Hence, I compared the 
sociodemographic and anthropometric differences between the PME and control groups 
using the Pearson Chi-square test and independent samples t-tests, as appropriate.  
Sociodemographic variables. Regarding age at testing, a two-tailed independent 




effect size. Specifically, children in the control group were slightly older than those in the 
PME group. Regarding sex distribution, Pearson‟s chi-squared test detected no significant 
between-group differences, although girls outnumbered boys in both the PME and control 
groups. 
Regarding language, Afrikaans was the mother tongue of all participants. The 
language data recorded in Table 4, however, are those relating to medium of school 
instruction (and, hence, language used in the assessment). Again, Pearson‟s chi-squared test 
detected no significant between-group differences in terms of language distribution, although 
the proportion of Afrikaans-administered participants was higher than that of English-
administered participants in both the PME and control groups.  
Regarding level of education, I defined this variable as the grade in which the 
participant was enrolled on the date of testing. As Table 4 shows, most participants were in 
Grade 1, and the ratio of Grade R to Grade 1 to Grade 2 participants varied slightly across 
both groups. However, Pearson‟s chi-squared test detected no significant between-group 
differences. 
Anthropometric variables. Independent samples t-tests detected no significant 
between-group differences regarding handedness, height, or head circumference. However, 
participants in the PME group weighed significantly less than those in the control group, a 











Table 4  
Demographic and Anthropometric Sample Characteristics for Participants and Mothers (N = 45) 
Note. In some cells, means are presented with standard deviations in parentheses; otherwise, data are 
presented in raw numbers/percentages. PME = prenatal methamphetamine exposure; ESE = estimate 
of effect size (r); M = male; F = female; Eng = English; Afr = Afrikaans; Gr = grade; L = left; R = 
right. The estimate of effect size was calculated using either r or ɸ, depending on whether an 
independent samples t-test or a Chi-square test was employed. 
aData missing for 2 mothers in PME group, and 2 mothers in the control group. 
bData missing for 2 mothers in PME group, and 6 mothers in the control group. 
cData missing for 7 mothers in PME group, and 2 mothers in the control group. 
dData missing for 2 mothers in the PME group, and 1 mother in the control group. 
eData missing for 1 mother in the PME group. 
fData missing for 1 mother in the PME group. 
*p < .05. **p < .01. ***p < .001.
Group 
PME Control 
Variable (n = 23) (n = 22) t / X2 p ESE 
Child 
Age  6.91 (0.42) 7.24 (0.38) 2.79 .008** .85 
Sex (M:F) 10:13 10:12 0.02 .89 .02 
Language (Eng:Afr) 5:18 7:15 0.58 .45 .11 
Education (GrR:Gr1:Gr2) 10:12:1 6:14:2 1.47 .48 .18 
Handedness (L:R) 1:22 0:22 0.93 .34 .15 
Weight (kg) 18.67 (2.44) 20.65 (3.45) 2.17 .04* .68 
Height (cm) 92.50 (8.32) 90.50 (7.04) -0.83 .41 .27 
Head circumference (cm) 51.41 (2.00) 52.63 (2.09) 1.98 .06 .61 
Mother 
Education (years)a 8.71 (1.35) 10.35 (2.30) 2.79 .008** .89 
Employment status (yes/no)b 4:17 12:4 5.80 .02* -.38 
Income bracketsc 12:3:1:0 10:2:4:4 5.81 .12 .40 
 <10 000 (n, %) 12 (75.00) 10 (50.00) 
 10 000 – 20 000 (n, %) 3 (18.75) 2 (10.00) 
 20 000 – 40 000 (n, %) 1 (6.25) 4 (20.00) 
 40 000 – 60 000 (n, %) 0 4 (20.00) 
Marital statusd 17:1:0:2:0 12:6:1:0:2 9.42 .05 .48 
 Single (n, %) 17 (85.00) 12 (60.00) 
 Married (n, %) 1 (5.00) 6 (28.57) 
 Living with partner (n, %) 0 1 (4.76) 
 Divorced (n, %) 2 (10.00) 0 
 Widowed (n, %) 0 2 (9.52) 
Cigarette use (yes/no)e 18:4 6:16 13.21 < .001** .55 
Alcohol use (yes/no)f 6:16 1:21 4.25 .04* .31 
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Maternal Sample Characteristics 
Analyses detected significant between-group differences regarding years of 
completed education, employment status, cigarette use, and alcohol use (see Table 4). 
Specifically, mothers of children in the control group had reached a higher level of education 
than those in the PME group (although, on average, mothers in both groups had attained no 
more than a high school education); this difference was associated with a large effect size. 
Similarly, a significantly greater number of mothers in the control group (compared to the 
PME group) were employed. Again, this difference was associated with a very large effect 
size. 
Regarding level of alcohol and cigarette exposure during pregnancy, there were, as 
expected, significant between-group differences. An important note here is that these data 
were categorical in nature. As stated earlier, the aim of the study was to collect information 
regarding the duration, frequency, and amount of drug, alcohol, and cigarette exposure during 
pregnancy; however, due to the difficulty in collecting accurate retrospective reports, a 
substantial number of participants simply answered “yes” or “no” to questions about prenatal 
substance use. Hence, I was only able to use categorical data in this case. Analyses of those 
data suggested that, overall, significantly more mothers in the PME group smoked cigarettes 
and drank alcohol during pregnancy. These between-group differences were associated with 
large and medium effect sizes, respectively.  
Cognitive Outcomes 
Hypothesis 1. I predicted that, compared to controls, children in the PME group 
would be impaired on measures of IQ, memory, language, and visual-motor integration and 
co-ordination. To test this prediction, I explored the descriptive statistics for all cognitive 




Across the entire dataset (i.e., the two groups‟ data collapsed together), the 
assumption of independence was met for all cognitive outcome variables. Inspection of the 
Q-Q plots, however, revealed potential departures from normality for several of those 
variables. I then ran Shapiro-Wilk tests to assess whether these departures from normality 
were statistically significant. The assumption of normality was not upheld for four of the 
KABC-II subtests (Hand Movements, Pattern Reasoning, Atlantis, and Atlantis Delayed) and 
for the GPT outcome variables. When examining the data distributions for each group 
separately, however, the analyses revealed that the assumption of normality was not upheld 
for several other outcome variables (see Table 5). Such within-group analysis was necessary 
because, given that subsequent analyses involved comparing the groups against one another, 
what is important is not the overall distribution of the data set, but rather the distribution in 
each group (Field, 2009). 
Table 5 
Results for Tests of Normality and Homogeneity of Variance for Cognitive Variables (N = 45)  
 Shapiro-Wilk Test  
Cognitive Measure PME Control Levene‟s test 
KABC-II NVI .04* .82 .87 
  Sequential Processing    
   Hand Movements .03* .58 .03* 
  Simultaneous Processing    
   Conceptual Thinking .23 .69 .76 
   Block Counting .34 .07 .26 
   Triangles .16 .36 .74 
  Planning Ability    
   Story Completion .14 .02* .85 
   Pattern Reasoning .05 .13 .79 
KABC-II: Learning Ability    
   Atlantis .15 .93 .06 
   Atlantis Delayed .07 .003** .52 
BNT-SA-SF .08 .03 .96 
Beery VMI .59 .75 .40 
  Visual score .22 .10 .66 
  Motor score .03* .61 .98 
Grooved Pegboard Test    
  Insertion time DH .03 .26 < .001*** 
  Insertion time NDH < .001*** .05* .01* 
Note. Data presented are p-values. PME = prenatal methamphetamine exposure; KABC-II = Kaufman 
Assessment Battery for Children – Second Edition; NVI = Non-Verbal Index; VMI = visual motor 
integration; BNT-SA-SF = Boston Naming Test (South African Short Form); DH = dominant hand; 




Similarly, the assumption of homogeneity, as determined by Levene‟s statistic, was 
not upheld for one of the KABC-II subtests (Hand Movements), and for the GPT dominant 
and non-dominant insertion time scores for the GPT, respectively (see Table 5). Because the 
data were not consistently normally distributed, I used the non-parametric Mann-Whitney U-
test to investigate between-group differences where appropriate. Otherwise, I used 
independent sample t-tests (in instances where the assumption of homogeneity was not 
upheld, I used separate estimates of variance). To control for inflated familywise error rate as 
a result of multiple pairwise comparisons, I calculated a Šídák multiple comparison 
correction [αPC = 1.0  -  (1.0 - αFW)1/K], which resulted in a critical value of p = .003 (there 
were 15 cognitive outcome variables in total).  
Table 6 presents descriptive statistics and results of between-group comparisons for 
the cognitive outcome variables. There were significant between-group differences across 
most of the KABC-II subtests (constituting sequential processing, simultaneous processing, 
planning ability, and learning ability), which were associated with large to very large effect 
sizes (ranging from r = .55 to r = .74), with the exception of one. Analyses of data from the 
Conceptual Thinking subtest (which assesses simultaneous processing) detected no 
significant between-group differences at the corrected p-value; these differences neared 
significance, however (p = .005). Overall, as expected, children in the PME group performed 
more poorly than those in the control group. Moreover, scores on the global IQ index, the 
NVI, also differed significantly between groups; this difference was associated with a large 
effect size. Again, children in the PME group achieved a significantly lower score on this 
measure than did those in the control group. 
Regarding performance on the BNT-SA-SF, the analysis detected significant 
between-group differences that were associated with a large effect size. On average, children 





Cognitive Outcome Variables: Descriptive statistics and between-group comparisons (N = 45) 
 Group     
 PME Control     
Cognitive Measure (n = 23) (n = 22) t / U df p ESE 
KABC-II NVIa 27.87 (6.79) 46.23 (7.52) 17.00 43 < .001*** .80 
 Sequential Processing       
  Hand Movementsa 7.04 (1.49) 10.64 (2.48) 56.52 43 < .001*** .67 
 Simultaneous Processing       
  Conceptual Thinkingb 5.33 (2.39) 9.50 (2.65) 2.95 14 .005** .62 
  Block Countingc 6.27 (3.38) 9.72 (1.97) 3.49 27 < .001*** .56 
  Triangles 5.43 (2.25) 8.77 (2.32) 4.89 43 < .001*** .60 
 Planning Ability       
  Story Completiona 4.96 (1.69) 8.23 (1.44) 37.5 43 < .001*** .74 
  Pattern Reasoning 4.65 (1.87) 8.77 (2.00) 7.13 43 < .001*** .74 
KABC-II:Learning Ability       
  Atlantis 5.65 (1.77) 8.82 (2.97) 4.36 43 < .001*** .55 
  Atlantis Delayed 6.74 (1.94) 9.59 (2.48) 93.00 43 < .001*** .55 
BNT-SA-SF 5.78 (1.67) 8.27 (1.49) 91.50 43 < .001*** .55 
Beery VMI 6.78 (2.95) 8.82 (2.59) 2.45 43 .009** .35 
  Visual score 6.78 (2.94) 9.59 (2.58) 3.40 43 < .001*** .46 
  Motor scorea 7.09 (1.86) 10.18 (1.84) 52.50 43 < .001*** .69 
Grooved Pegboard Test       
  Insertion time DHa 75.00 (24.36) 45.36 (7.35) 42.50 43 < .001*** .71 
  Insertion time NDHa 98.04 (41.18) 54.05 (14.90) 89.00 43 < .001*** .66 
Note. Data are scaled score means, with standard deviations in parentheses, except for the BNT and 
Grooved Pegboard Test, where raw scores are presented. Similarly, the t/U and p values presented 
here are based on analyses of scaled scores for most variables, and of z-scores for the BNT-SA-SF 
and Grooved Pegboard Test. PME = prenatal methamphetamine exposure; KABC-II = Kauffman 
Assessment Battery for Children – Second Edition; NVI = Non-verbal Index; BNT-SA-SF = Boston 
Naming Test (South African Short Form); VMI = visual-motor integration; DH = dominant hand; 
NDH = non-dominant hand; ESE = estimate of effect size (in this case, r). Test statistics were either t 
or U, depending on whether data were normally distributed or not. 
aThe assumption of normality was violated, so the Mann-Whitney U test was used. 
bData unavailable for 11 children in the PME group and 18 children in the control group as composite 
tests for the NVI varied for children aged 6 and those aged 7; specifically, Conceptual Thinking was 
only administered to children aged 6 years. 
cData unavailable for 12 children in the PME group and 4 children in the control group as composite 
test for the NVI varied for children aged 6 and those aged 7; specifically Block Counting was only 
administered to children aged 7 years. 
*p < .05. **p < .01. ***p < .001 
 
Similarly, children in the PME group generally performed significantly more poorly 
than those in the control group on the Beery VMI. Specifically, they committed a greater 
number of errors when asked to copy the series of geometric shapes. The between-group 




neared such significance (p = .009). This pattern of performance was repeated at a significant 
level on both the visual perceptual and motor subtests of the Beery, and was associated with 
medium and large effect sizes, respectively. 
Finally, regarding the GPT, children in the PME group performed significantly more 
poorly than those in the control group, for both dominant and non-dominant hand removal 
times. These between-group differences were both associated with very large effect sizes. 
 
Secondary Analyses 
Given the discrepancy between home language and language of test administration 
(Barac & Bialystok, 2012), and the potentially confounding effects of sex (Halpern, 2013) on 
cognitive outcomes, I conducted secondary analyses to explore the potential impact of 
within-group differences in language and sex on test performance. I used the non-parametric 
Mann-Whitney U-test to investigate between-group differences where data were not normally 
distributed. Otherwise, I administered independent sample t-tests. Of note here is that the 
corrected p-value (p = .003), adjusted for multiple comparisons, was retained.  
There were no significant within-group differences in cognitive performance when 
comparing English-administered to Afrikaans-administered children: For the control group, p 
ranged from .01 to .44, and for the PME group, p ranged from .03 to .50. Similarly, there 
were no significant within-group differences in cognitive performance when comparing boys 
to girls: For the control group, p ranged from .01 to .48, and for the PME group, p ranged 








Hierarchical Regression Analysis 
Hypothesis 2. I predicted that the cognitive deficits observed in the PME group 
would be related to the effects of drug exposure, and not to the effects of potential 
confounding variables.  
Examination of the relationship between PME, cognitive outcomes, and potential 
confounding variables began with construction of a correlation matrix (see Table 7). The aim 
of this analytic step was to assess associations between all the cognitive outcomes and the 
following potential confounding variables: child‟s age at testing, child‟s weight, maternal 
education level, maternal employment status, maternal cigarette use, and maternal alcohol 
use. To increase the strength of PME-related interpretations, variables that were even weakly 
related (at p < .10) to a given cognitive outcome were considered for inclusion in the 
regression models. 
Based on the results of tests of normality, the Pearson r coefficient was used for 
correlations involving child‟s age at testing and weight, whereas Spearman‟s ρ coefficient 
was used for correlations involving maternal education level, maternal employment status, 
and maternal cigarette and alcohol use. As Table 7 shows, all of the above-mentioned 
potential confounders correlated significantly with several cognitive outcomes.  
Due to considerations of sample size in relation to the reliability (and power) of the 
regression model, I selected five predictors (guided by both theory and the correlation matrix 
data) for inclusion in subsequent regression models: child‟s age at testing, child‟s weight at 
testing, maternal education level, maternal alcohol exposure, and the main variable of interest, 
PME status. I included maternal level of education in the models because the between-group 
differences for that variable were significantly greater than those related to employment 
status (see Table 4). Furthermore, maternal level of education is highly correlated with 
employment status, and previous research has found maternal level of education to have a 
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significant influence on child development (see, e.g., Bornstein & Bradley, 2014). To 
conserve statistical power, I could not include both cigarette and alcohol exposure in the 
regression models. I decided to exclude the former because all the mothers in the PME group 
who used alcohol also smoked, and thus it would be problematic to separate out the effects of 
the two variables. A recent study corroborates this observed trend, reporting that maternal 
smoking is associated with an increased risk of prenatal alcohol exposure (Williams, Nkombo, 
Nkodia, Leonardson, & Burd, 2014). 
Table 7  
Correlations for Cognitive Outcomes and Potential Confounding Variables (N = 45) 
Child Mother 







KABC-II NVI .26 † .48*** .57*** .41** -.24 -.58*** 
Sequential Processing 
 Hand Movements .30* .41** .58*** .33* -.06 -.46** 
Simultaneous Processing 
Conceptual Thinking -.12 .36 .29 .32 .10 -.68** 
Block Counting .03 .40* .29 .22 -.27 -.36* 
Triangles .24 .45** .47** .26 † -.30* -.43* 
Planning Ability 
Story Completion .05 .34* .49*** .45** -.19 -.53*** 
 Pattern Reasoning .22 .37* .53*** .32* -.32* -.51*** 
KABC-II: Learning Ability 
Atlantis .10 .31* .60*** .47** .06 -.34* 
Atlantis Delayed .27 † .14 .22 .28 † -.18 -.31* 
BNT -.03 .35* .49** .45** -.14 -.37* 
Beery VMI .37** .41** .34* .003 -.04 -.31* 
 Visual score .30* .27 † .18 -.02 -.12 -.33* 
 Motor score .30* .28* .30 † .21 -.22 -.56*** 
Grooved Pegboard 
Insertion time DH -.34* -.26 † -2.70 † -.23 .14 .36* 
Insertion time NDH -.09 -.16 -.16 -.11 .06 .30* 
Note. Statistics presented are Spearman correlation coefficients (ρ) unless otherwise stated. All tests 
are 2-tailed. KABC-II = Kaufman Assessment Battery for Children - Second Edition; BNT-SA-SF = 
Boston Naming Test (South African Short Form); VMI = visual-motor integration; DH = dominant 
hand; NDH = non-dominant hand. 
aStatistic presented is Pearson correlation coefficient (r).  
†p < .10. *p < .05. **p < .01. ***p < .001. 
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To examine the degree to which the above-mentioned potential confounding variables 
influenced the association between PME and cognitive outcomes, I conducted a separate 
hierarchical regression analysis for each of the 15 outcome variables of interest. The 
confounding variables I wished to control for (child‟s age at testing, child‟s weight at testing, 
maternal level of education, maternal alcohol exposure) were entered as a block at the first 
step in the model, and exposure status (PME group versus control group) was entered at the 
second step. 
All assumptions underlying the regression models (viz., multicollinearity [determined 
by tolerance statistics and the mean VIF value for each model], independence of model 
residuals [determined by the Durbin-Watson statistic], homoscedasticity [determined by the 
plot of standardized residuals against standardized predicted residuals], and normality of 
standardized residuals [determined by visual inspection of the histogram and normal 
probability plot]) were upheld for each model, unless otherwise specified. Regarding 
regression model diagnostics, unless otherwise specified Cook‟s distance was within 
acceptable limits (i.e., < 1), and Mahalanobi‟s distance was below the conventional cut-off of 
15, indicating no multivariate outliers (Field, 2009). 
Model 1: Predicting performance on the KABC-II Non-Verbal IQ score. At step 
1 of the hierarchical multiple regression, I entered the following four predictors: child‟s age 
at testing, child‟s weight at testing, maternal level of education, and maternal alcohol 
exposure during pregnancy. Table 8 shows that, at this step, the model was statistically 
significant, explaining 48.2% of the variance in the KABC-II NVI scores, F(4, 35) = 8.16, p 
< .001. The introduction of group status (PME versus control) at step 2 explained an 
additional 25.6% of the variance in the NVI scores. In the final model, only maternal level of 




Overall, the final inclusive model accounted for 74.1% of the variance in NVI scores, F(5, 34) 
= 19.41, p < .001. 
Table 8 
Hierarchical Regression Model 1: Performance on the KABC-II NVIa, predicted by potential 
confounding variables and group status (N = 45) 
Variable Entered B SE B β 
 Step 1    
  Constant -50.44 24.68  
  Child age at testing 6.59 3.38 0.24 
  Child weight at testing 0.73 0.53 0.20 
  Maternal education 2.81 0.81 0.49*** 
  Maternal alcohol exposure -4.25 3.90 -0.14 
 Step 2    
  Constant 20.43 21.63  
  Child age at testing -0.24 2.71 -0.01 
  Child weight at testing 0.58 0.38 0.15 
  Maternal education 1.51 0.62 0.26* 
  Maternal alcohol exposure 0.55 2.93 0.02 
  Group status  -14.95 2.59 -0.065*** 
Note. KABC-II NVI = Kauffman Assessment Battery for Children – Second Edition, Non-verbal 
Index; R2 = .48 for Step 1, ΔR2 = .26 for Step 2 (p < .001). 
aThe Non-verbal Index of the KABC-II constitutes the following subtests: Hand Movements, 
Conceptual Thinking (for 6-year-olds only), Block Counting (for 7-year-olds only), Triangles, Story 
Completion, and Pattern Reasoning. 
*p < .05. **p < .01. ***p < .001.  
 
Model 2: Predicting performance on the KABC-II Sequential Processing subtest. 
I entered the aforementioned potential confounding variables and PME as two separate steps 
into this hierarchical regression model. Table 9 shows that age at testing, weight at testing, 
maternal level of education, and alcohol exposure explained 49.7% of the variance in Hand 
Movements scores, F(4, 35) = 8.65, p < .001. The introduction of group status at step 2 of the 
model explained an additional 13.6% of the variance in the outcome scores. In the final 
model, only maternal level of education and group status remained statistically significant 
predictors of sequential processing abilities. Overall, the final inclusive model accounted for 










Hierarchical Regression Model 2: Performance on the KABC-II Sequential Processing subtests, 
predicted by potential confounding variables and group status (N = 45) 
Variable Entered B SE B β 
 Step 1    
  Constant -13.94 5.65  
  Child age at testing 1.93 0.77 0.31* 
  Child weight at testing 0.07 0.12 0.08 
  Maternal education 0.81 0.18 0.60*** 
  Maternal alcohol exposure 0.23 0.89 0.03 
 Step 2    
  Constant -1.96 5.95  
  Child age at testing 0.78 0.75 0.12 
  Child weight at testing 0.04 0.11 0.05 
  Maternal education 0.59 0.17 0.44** 
  Maternal alcohol exposure 1.04 0.81 0.14 
  Group status  -2.53 0.71 -0.47*** 
Note. KABC-II = Kaufman Assessment Battery for Children – Second Edition. R2 = .50 for Step 1, 
ΔR2 = .14 for Step 2 (p < .001). 
*p < .05. **p < .01. ***p < .001.  
 
 
Models 3-5: Predicting performance on the KABC-II Simultaneous Processing 
subtests. I entered the aforementioned potential confounding variables and group status as 
two separate steps, respectively, into hierarchical regression models for the three KABC-II 
subtests that measure simultaneous processing ability: Conceptual Thinking, Block Counting, 
and Triangles.  
Model 3: Conceptual Thinking. Table 10 shows that the set of potential confounding 
variables had no significant predictive value for Conceptual Thinking scores, F(4, 9) = 0.60, 
p = .67. The introduction of group status at step 2, however, explained 50.9% of the variance 
in Conceptual Thinking scores, F(5, 8) = 4.12, p < .01. In the final model, only child‟s age at 
testing and group status were statistically significant predictors of conceptual thinking 
abilities. 
Of note here is that the Conceptual Thinking subtest was administered to 6-year-olds 
only (as per manual specifications), and so the results from this regression model must be 
interpreted with caution as the power of the regression analysis was compromised by the 




distribution of data between exposure groups) were further evidenced by the plot of 
standardized residuals against standardized predicted residuals, which indicated that the 
assumption of homoscedasticity was not upheld. Hence, one should exercise caution when 
attempting to generalize this model beyond this sample (Field, 2009). 
Model 4: Block Counting. Table 10 shows that the set of potential confounding 
variables had no significant predictive value for Block Counting scores, F(4, 22) = 1.52, p 
= .23. The introduction of group status at step 2 of the model, however, explained 20.5% of 
the variance in Block Counting scores, F(5, 21) = 3.07, p < .01. In the final model, only 
group status was a statistically significant predictor of block counting abilities.  
Of note here is that the Block Counting subtest was administered to 7-year-olds only 
(as per manual specifications), and so the results of this regression model must be interpreted 
with caution as the power of the regression analysis was compromised by the reduced sample 
size (n = 29). Visual inspection of the P-P plot of standardized residuals suggested that the 
assumption of normality was violated. Hence, one should exercise caution when attempting 
to generalize this model beyond this sample (Field, 2009). 
Model 5: Triangles. Table 10 shows that the set of potential confounding variables 
explained 38.8% of the variance in the Triangles subtest scores, F(4, 35) = 5.56, p < .001. 
The introduction of group status at step 2 of the model explained an additional 9% of the 
variance in the outcome. In the final model, only PME status remained a statistically 
significant predictor of abstract constructional abilities. Overall, the final inclusive model 














Hierarchical Regression Models 3-5: Performance on the KABC-II Simultaneous Processing subtests, 
predicted by potential confounding variables and group status 
Variable Entered B SE B β 
Model 3: Conceptual Thinking (N = 16)a 
 Step 1    
  Constant 5.85 15.49  
  Child age at testing -1.19 2.12 -0.17 
  Child weight at testing 0.31 0.33 0.32 
  Maternal education 0.27 0.51 0.18 
  Maternal alcohol exposure 1.30 2.45 0.16 
 Step 2    
  Constant 31.61 11.89  
  Child age at testing -3.68 1.49 -0.53* 
  Child weight at testing 0.25 0.21 0.26 
  Maternal education -0.20 0.34 -0.14 
  Maternal alcohol exposure 3.05 1.61 0.37 
  Group status  -5.44 1.43 -0.91** 
 
Model 4: Block Counting (N = 29)b 
 Step 1    
  Constant 2.28 10.02  
  Child age at testing -0.23 1.37 -0.03 
  Child weight at testing 0.32 0.22 0.33 
  Maternal education 0.18 0.33 0.12 
  Maternal alcohol exposure -1.69 1.58 -0.21 
 Step 2    
  Constant 18.88 10.71  
  Child age at testing -1.83 1.34 -0.26 
  Child weight at testing 0.28 0.19 0.29 
  Maternal education -0.13 0.31 -0.09 
  Maternal alcohol exposure -0.57 1.45 -0.07 
  Group status  -3.50 1.28 -0.58** 
 
Model 5: Triangles (N = 45)c 
 Step 1    
  Constant -11.00 6.49  
  Child age at testing 1.34 0.89 0.21 
  Child weight at testing 0.21 0.14 0.23 
  Maternal education 0.49 0.21 .036* 
  Maternal alcohol exposure -1.59 1.03 -0.21 
 Step 2    
  Constant -0.86 7.40  
  Child age at testing 0.37 0.93 0.06 
  Child weight at testing 0.19 0.13 0.21 
  Maternal education 0.31 0.21 0.22 
  Maternal alcohol exposure -0.90 1.00 -0.12 
  Group status  -2.14 0.89 -0.38* 
Note. KABC-II = Kaufman Assessment Battery for Children – Second Edition. 
aR2 = .21 for Step 1, ΔR2 = .51 for Step 2 (p < .05). 
bR2 = .22 for Step 1, ΔR2 = .21 for Step 2 (p < .05). 
cR2 = .39 for Step 1, ΔR2 = .09 for Step 2 (p < .001). 
*p <.05. **p < .01. ***p < .001.  
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Models 6-7: Predicting performance on the KABC-II Planning Ability subtests. I 
created similar hierarchical regression models as above for two KABC-II subtests that 
measure planning ability: Story Completion and Pattern Reasoning. 
Table 11 
Hierarchical Regression Models 6-7:Performance on the KABC-II Planning Ability subtests, 
predicted by potential confounding variables and group status (N = 45) 
Variable Entered B SE B β 
Model 6: Story Completiona 
Step 1 
Constant -1.40 5.61 
Child age at testing 0.22 0.77 0.04 
Child weight at testing 0.09 0.12 0.12 
Maternal education 0.51 0.18 0.45** 
Maternal alcohol exposure -0.58 0.89 -0.09
Step 2 
Constant 14.68 4.92 
Child age at testing -1.33 0.62 -0.25*
Child weight at testing 0.05 0.09 0.07
Maternal education 0.21 0.14 0.19
Maternal alcohol exposure 0.52 0.67 0.08
Group status  -3.39 0.59 -0.76***
Model 7: Pattern Reasoningb 
Step 1 
Constant -11.20 6.37 
Child age at testing 1.44 0.87 0.22 
Child weight at testing 0.08 0.14 0.09 
Maternal education 0.67 0.21 0.48** 
Maternal alcohol exposure -1.64 1.01 -0.22
Step 2 
Constant 4.42 6.28 
Child age at testing -0.07 0.79 -0.01
Child weight at testing 0.04 0.11 0.05
Maternal education 0.38 0.18 0.28*
Maternal alcohol exposure -0.58 0.85 -0.08
Group status  -3.30 0.75 -0.59***
Note. KABC-II = Kaufman Assessment Battery for Children – Second Edition. 
aR2 = .30 for Step 1, ΔR2 = .35 for Step 2 (p < .001).
bR2 = .41 for Step 1, ΔR2 = .21 for Step 2 (p < .001).
*p < .05. **p < .01.  ***p < .001.
Model 6: Story Completion. Table 11 shows that the set of potential confounding 
variables explained 29.5% of the variance in the Story Completion subtest scores, F(4, 35) = 
3.67, p < .05. The introduction of group status at step 2 of the model explained an additional 




group status remained statistically significant predictors of sequential reasoning ability. 
Overall, the final inclusive model accounted for 64.3% of the variance in Story Completion 
scores, F(5, 34) = 12.24, p < .001.  
Model 7: Pattern Reasoning. Table 11 shows that the set of potential confounding 
variables explained 34.6% of the variance in the Pattern Reasoning subtest scores, F(4, 35) = 
6.16, p < .001. The introduction of group status at step 2 of the model explained an additional 
21.2% of the variance in the outcome. In the final model, only maternal level of education 
and group status remained statistically significant predictors of abstract reasoning ability. 
Overall, the final inclusive model accounted for 62.5% of the variance in Pattern Reasoning 
scores, F(5, 34) = 11.33, p < .001.  
Models 8-9: Predicting performance on the KABC-II Learning Ability subtests. I 
created similar hierarchical regression models as above for two KABC-II subtests that 
measure learning and delayed recall ability: Atlantis and Atlantis Delayed. 
Model 8: Atlantis. Table 12 shows that the set of potential confounding variables 
explained 45.1% of the variance in the Atlantis subtest scores, F(4, 35) = 7.20, p < .001. The 
introduction of group status at step 2 of the model explained an additional 11.3% of the 
variance in the outcome. In the final model, only maternal level of education and group status 
remained statistically significant predictors of learning ability. Overall, the final inclusive 
model accounted for 56.5% of the variance in Atlantis scores, F(5, 34) = 8.83, p < .001.  
Model 9: Atlantis Delayed. Table 12 shows that the set of potential confounding 
variables was not a significant predictor of Atlantis Delayed subtest scores, F(4, 35) = 1.97, p 
= .12. The introduction of group status at step 2 of the model, however, explained 14.1% of 
the variance in outcome, F(5, 34) = 3.27, p < .01. In the final model, only group status 
remained a statistically significant predictor of delayed recall ability. However, the plot of 
standardized residuals against standardized predicted residuals indicated that the assumption 
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of homoscedasticity was not upheld for this model, and so one must exercise caution when 
generalizing this finding beyond this sample (Field, 2009). 
Table 12 
Hierarchical Regression Models 8-9: Performance on the KABC-II Learning Ability subtests, 
predicted by potential confounding variables and group status (N = 45) 
Variable Entered B SE B β 
Model 8: Atlantisa 
Step 1 
Constant -7.89 6.29 
Child age at testing 0.87 0.86 0.13 
Child weight at testing -0.03 0.14 -0.03
Maternal education 0.98 0.21 0.69*** 
Maternal alcohol exposure 0.81 0.99 0.10 
Step 2 
Constant 3.80 6.91 
Child age at testing -0.26 0.87 -0.04
Child weight at testing -0.05 0.12 -0.06
Maternal education 0.77 0.20 0.54*** 
Maternal alcohol exposure 1.60 0.94 0.21 
Group status  -2.47 0.83 -0.43**
Model 9: Atlantis Delayedb 
Step 1 
Constant -7.14 6.97 
Child age at testing 1.79 0.96 0.29 
Child weight at testing -0.07 0.15 -0.08
Maternal education 0.43 0.23 0.33
Maternal alcohol exposure -0.71 1.10 -0.10
Step 2 
Constant 4.69 7.82 
Child age at testing 0.64 0.98 0.11 
Child weight at testing -0.10 0.14 -0.11
Maternal education 0.21 0.23 0.17
Maternal alcohol exposure 0.09 1.06 0.01
Group status  -2.50 0.94 -0.48**
Note. KABC-II = Kaufman Assessment Battery for Children – Second Edition. 
aR2 = .45 for Step 1, ΔR2 = .11 for Step 2 (p < .001).
bR2 = .18 for Step 1, ΔR2 = .14 for Step 2 (p < .001).
*p < .05. **p < .01.  ***p < .001.
Model 10: Predicting performance on the BNT-SA-SF. Table 13 shows that the set 
of potential confounding variables explained 29.9% of the variance in BNT-SA-SF scores, 
F(4, 35) = 3.73, p < .05. The introduction of group status at step 2 of the model explained an 
additional 20.3% of the variance in the outcome. In the final model, only group status 




final inclusive model accounted for 50.2% of the variance in BNT-SA-SF scores, F(5, 34) = 
6.85, p < .001. 
Table 13 
Hierarchical Regression Model 10: Performance on the BNT-SA-SF, predicted by potential 
confounding variables and group status (N = 45) 
Variable Entered B SE B β 
 Step 1    
  Constant -5.09 3.09  
  Child age at testing 0.02 0.42 0.01 
  Child weight at testing 0.11 0.07 0.27 
  Maternal education 0.22 0.10 0.35* 
  Maternal alcohol exposure -0.16 0.49 -0.05 
 Step 2    
  Constant 1.70 3.21  
  Child age at testing -0.64 0.40 -0.22 
  Child weight at testing 0.09 0.06 0.23 
  Maternal education 0.09 0.09 0.15 
  Maternal alcohol exposure 0.30 0.44 0.09 
  Group status  -1.43 0.39 -0.58*** 
Note. BNT-SA-SF = Boston Naming Test (South African Short From). R2 = .30 for Step 1, ΔR2 = .20 
for Step 2 (p < .001). 
*p < .05. **p < .01. ***p < .001.  
 
Models 11-13: Predicting performance on the Beery VMI subtests. I created 
similar hierarchical regression models as above for the Beery VMI primary score, and the 
two subtest scores: the Visual Perception Test score and the Motor Co-ordination Test score. 
Model 11: Beery VMI.  Table 14 shows that the set of potential confounding 
variables explained 32.7% of the variance in Beery VMI subtest scores, F(4, 35) = 4.26, p 
< .05. The introduction of group status at step 2 of the model explained an additional 0.2% of 
the variance in the outcome. In the final model, only child‟s age at testing remained a 
statistically significant predictor, suggesting that PME was not a significant predictor of 
performance on this task of visual-motor integration. Overall, the final inclusive model 









Hierarchical Regression Models 11-13: Performance on the Beery VMI, predicted by potential 
confounding variables and group status (N = 45) 
Variable Entered B SE B β 
Model 11: Beery VMIa 
Step 1 
Constant -17.05 7.09 
Child age at testing 2.37 0.97 0.35* 
Child weight at testing 0.20 0.15 0.22 
Maternal education 0.43 0.23 0.29 
Maternal alcohol exposure 0.18 1.12 0.02 
Step 2 
Constant -15.58 8.72 
Child age at testing 2.23 1.09 0.33* 
Child weight at testing 0.20 0.15 0.21 
Maternal education 0.40 0.25 0.28 
Maternal alcohol exposure 0.28 1.18 0.04 
Group status  -0.31 1.05 -0.05
Model 12: Visual Perceptionb 
Step 1 
Constant -10.58 8.32 
Child age at testing 1.98 1.13 0.28 
Child weight at testing 0.17 0.18 0.17 
Maternal education 0.17 0.27 0.11 
Maternal alcohol exposure -0.56 1.32 -0.07
Step 2 
Constant 0.47 9.70 
Child age at testing 0.91 1.22 0.13 
Child weight at testing 0.14 0.17 0.14 
Maternal education -0.04 0.28 -0.03
Maternal alcohol exposure 0.19 1.32 0.02
Group status  -2.33 1.16 -0.38*
Model 13: Motor Co-ordinationc 
Step 1 
Constant -7.59 6.19 
Child age at testing 1.64 0.85 0.29 
Child weight at testing 0.05 0.13 0.07 
Maternal education 0.38 0.20 0.32 
Maternal alcohol exposure -0.59 0.98 -0.09
Step 2 
Constant 5.51 6.53 
Child age at testing 0.38 0.82 0.07 
Child weight at testing 0.02 0.12 0.03 
Maternal education 0.14 0.19 0.12 
Maternal alcohol exposure 0.30 0.89 0.05 
Group status  -2.77 0.78 -0.58***
Note. Beery VMI = Beery Developmental Test of Visual-Motor Integration. 
aR2 = .33 for Step 1, ΔR2 = .002 for Step 2 (p < .05).
bR2 = .16 for Step 1, ΔR2 = .09 for Step 2 (p = .07).
cR2 = .24 for Step 1, ΔR2 = .21 for Step 2 (p < .001).
*p < .05. **p < .01. ***p < .001.
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Model 12: Beery Visual Perception Test. Table 14 shows that at neither the first nor 
the second modeling step was there a significant set of predictors for scores on the Beery 
Visual Perception Test, F(4, 35) = 1.63, p = .19, and F(5, 34) = 2.23, p = .07, respectively. 
Group status, however, trended strongly toward significance in the final model (p = .05).  
Model 13: Beery Motor Co-ordination Test. Table 14 shows that the set of potential 
confounding variables explained 23.5% of the variance in Beery Motor Co-ordination subtest 
scores, F(4, 35) = 2.68, p < .05. The introduction of group status at step 2 of the model 
explained an additional 20.6% of the variance in the outcome. In the final model, only group 
status remained a significant predictor of motor coordination performance. Overall, the final 
inclusive model accounted for 44.0% of the variance in Beery Motor Co-ordination scores, 
F(5, 34) = 5.35, p < .001.  
Models 14-15: Predicting performance on the GPT outcome variables. I created 
similar hierarchical regression models as above for two GPT variables: Insertion Time 
(dominant hand) and Insertion Time (non-dominant hand). 
Model 14: GPT insertion time, dominant hand. Table 15 shows that the set of 
potential confounding variables was not a significant predictor of GPT dominant hand 
insertion times, F(4, 35) = 2.36, p = .07. The introduction of group status at step 2, however, 
explained 18.8% of the variance in the outcome, F(5, 34) = 3.27, p < .01. In the final model, 
only group status remained a statistically significant predictor, demonstrating the independent 
effect of PME on dominant-hand fine motor co-ordination. However, the plot of standardized 
residuals against standardized predicted residuals indicated that the assumption of 
homoscedasticity was not upheld for this model, and so one must exercise caution when 
generalizing this finding beyond this sample (Field, 2019). 
Model 15: GPT insertion time, non-dominant hand. Table 15 shows that the set of 
potential confounding variables was not a significant predictor of GPT non-dominant hand 
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insertion times, F(4, 35) = 0.43, p = .79. The introduction of group status at step 2 of the 
model, however, explained 23.8% of the variance in the outcome, F(5, 34) = 2.71, p < .05. 
Table 15 
Hierarchical Regression Models 14-15: Performance on the GPT, predicted by potential confounding 
variables and group status (N = 45) 
Variable Entered B SE B β 
Model 14: Insertion Time – Dominant Handa 
Step 1 
Constant 25.99 8.74 
Child age at testing -2.64 1.20 -0.34*
Child weight at testing -0.09 0.19 -0.08
Maternal education -0.38 0.29 -0.23
 Maternal alcohol exposure 0.75 1.38 0.08
Step 2 
Constant 8.55 9.39 
Child age at testing -0.96 1.17 -0.12
Child weight at testing -0.05 0.17 -0.04
Maternal education -0.06 0.27 -0.04
Maternal alcohol exposure -0.43 1.27 -0.05
Group status  3.68 1.13 0.56**
Model 15: Insertion time – Non-dominant Handb 
Step 1 
Constant 7.59 8.61 
Child age at testing -0.31 1.18 -0.05
Child weight at testing -0.14 0.19 -0.15
Maternal education -0.13 0.28 -0.08
Maternal alcohol exposure 0.24 1.36 0.03
Step 2 
Constant -9.99 9.20 
Child age at testing 1.39 1.15 0.20 
Child weight at testing -0.10 0.16 -0.10
Maternal education 0.20 0.27 0.14
Maternal alcohol exposure -0.95 1.25 -0.12
Group status 3.71 1.10 0.63**
Note. GPT = Grooved Pegboard Test. 
aR2 = .21 for Step 1, ΔR2 = .19 for Step 2 (p < .05). 
bR2 = .05 for Step 1, ΔR2 = .24 for Step 2 (p < .05).
*p < .05. **p < .01. ***p < .001.
 In the final model, only group status remained a statistically significant predictor, 
demonstrating the independent effect of PME on non-dominant hand fine motor co-
ordination. However, visual inspection of the P-P plot of standardized residuals suggested 
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that the assumption of normality was violated, and so one must exercise caution when 
generalizing this finding beyond this sample (Field, 2009). 
Imaging Analysis 
Sample characteristics. Of the 45 participants originally enrolled in this study (see 
Table 4), 80% (n = 36; 19 PME, 17 controls) completed the scanning procedure. In all 
instances where no scanning sequences were acquired, the participants (within the rights of 
their consent agreements) refused to continue with the scan due to anxiety and/or fear of the 
scanner. Of the 36 scans obtained, 72.22% (n = 26; 13 PME, 13 controls) had successful 
structural and resting state sequences; scans from the other 10 participants were unusable due 
to motion and/or noise artifacts.  
To ensure that the whole-sample trends described in the Cognitive Outcomes section 
were similar in this sub-group of participants, I re-ran similar between-group comparisons as 
described above for this sub-sample‟s demographic, anthropometric, and cognitive outcome 
variables. The relevant data are presented in Tables 16 and 17.  
Regarding the child demographic and anthropometric variables, there were no 
significant between-group differences in this sub-sample. Regarding maternal demographic 
variables, there were significant between-group differences in the distribution of marital 
status. Notably, most mothers (84.62%) in the PME group were single, and the rest were 
divorced; in contrast, less than half (46.15%) of the mothers in the control group were single, 
and none were divorced. As was the case in the larger sample, significantly more mothers in 
the PME group than in the control group were exposed to nicotine during pregnancy. 
Regarding cognitive outcomes, the data were not consistently normally distributed. 
Hence, I used the non-parametric Mann-Whitney U-test to investigate between-group 
differences where appropriate. Otherwise, I administered independent sample t-tests. 
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Table 16 
Demographic and Anthropometric Sample Characteristics, for Participants and Mothers (N = 26) 
Note. In some cells, means are presented with standard deviations in parentheses; otherwise, data are 
presented in ratios. PME = prenatal methamphetamine exposure; ESE = estimate of effect size; M = 
male; F = female; Eng = English, Afr = Afrikaans; Gr = grade; L = left, R = right. The estimate of 
effect size was calculated using either r or ɸ, depending on whether an independent samples t-test or 
Chi-square test was employed. 
aData missing for 1 mother in the control group. 
bData missing for 3 mothers in the PME group, and 1 mother in the control group. 
*p < .05. **p < .01. ***p < .001.
Group 
PME Control 
Variable (n = 13) (n = 13) t / X2 p ESE 
Child 
Age at testing 6.99 (.41) 7.23 (.27) 1.71 .10 .69 
Sex (M:F) 5:8 6:7 0.16 .69 .08 
Language (Eng:Afr) 2:11 3:10 0.25 .62 .10 
Education (GrR:Gr1:Gr2) 5:8:0 4:8:1 1.11 .57 .21 
Handedness (L:R) 0:13 0:13 
Weight (kg) 19.16 (2.75) 19.87 (3.45) 0.62 .54 .25 
Height (cm) 91.42 (7.84) 90.46 (8.01) -0.31 .76 .13 
Head circumference (cm) 51.85 (1.95) 52.10 (1.96) 0.33 .74 .13 
Mother 
Education (years)a 8.92 (1.44) 10.00 (2.45) 1.35 .19 .56 
Employment status (yes/no) 3:10 7:6 2.60 .11 -.32 
Income bracketsb 8:2:0:0 6:1:3:2 5.48 .14 .50 
 <10 000 (n, %) 8 (80.00) 6 (50.00) 
 10 000 – 20 000 (n, %) 2 (20.00) 1 (8.33) 
 20 000 – 40 000 (n, %) 0 3 (25.00) 
 40 000 – 60 000 (n, %) 0 2 (16.67) 
Marital status 11:0:0:2:0 6:5:1:0:1 10.47 .03* .64 
 Single (n, %) 11 (84.62) 6 (46.15) 
 Married (n, %) 0 5 (38.46) 
 Living with partner (n, %) 0 1 (7.69) 
 Divorced (n, %) 2 (15.38) 0 
 Widowed (n, %) 0 1 (7.69) 
Cigarette use (yes/no) 11:2 4:9 7.72 .005** .55 
Alcohol use (yes/no) 4:9 1:12 2.23 .14 .29 
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Table 17 
Cognitive Outcome Variables: Descriptive Statistics and Between-Group Comparisons (N = 26) 
Group 
PME Control 
Cognitive Measure (n = 13) (n = 13) t / U df p ESE 
KABC-II NVI 27.92 (7.74) 44.31 (6.81) 5.73 24 < .001*** .76 
Sequential Processing 
 Hand Movements 7.23 (1.69) 10.00 (2.68) 3.15 24 .002** .54 
Simultaneous Processing 
Conceptual Thinkingac 4.67 (.82) 9.00 (1.41) 0.00 6 .04* .73 
Block Countingb 7.29 (3.30) 9.45 (1.97) 19.00 16 .04* .42 
 Triangles 5.31 (2.56) 8.54 (1.81) 3.72 24 < .001*** .60 
Planning Ability 
Story Completionc 4.46 (1.71) 8.00 (1.53) 11.00 24 < .001*** .77 
Pattern Reasoningc 4.85 (1.91) 8.15 (1.95) 20.00 24 < .001*** .66 
Learning Ability 
Atlantis 5.54 (1.51) 8.08 (2.57) 3.08 24 .003** .53 
 Atlantis Delayedc 6.62 (1.90) 9.31 (1.49) 19.50 24 < .001*** .67 
BNT-SA-SF 6.08 (1.75) 8.31 (1.75) 3.17 24 .002** .54 
Beery VMI 7.46 (3.26) 8.85 (2.91) 1.14 24 .13 .23 
Visual score 7.38 (2.96) 9.31 (2.56) 1.77 24 .04* .34 
Motor score 7.23 (1.48) 9.62 (1.56) 4.00 24 < .001*** .63 
Grooved Pegboard Test 
Insertion time DHc 69.62 (19.89) 48.77 (7.19) 25.00 24 .001*** .60 
Insertion time NDHc 99.38 (45.02) 54.31 (13.31) 36.50 24 .006** .48 
Note. Data are scaled score means, with standard deviations in parentheses, except for the BNT and 
Grooved Pegboard Test, where raw scores are presented. Similarly, the t/U and p values presented 
here are based on analyses of scaled scores for most variables, and of z-scores for the BNT-SA-SF 
and Grooved Pegboard Test. PME = prenatal methamphetamine exposure; KABC-II = Kauffman 
Assessment Battery for Children – Second Edition; NVI = Non-Verbal Index; BNT-SA-SF = Boston 
Naming Test (South African Short Form); VMI = visual-motor integration; DH = dominant hand; 
NDH = non-dominant hand; ESE = estimate of effect size (in this case, r).  
aData unavailable for 7 children in the PME group and 11 children in the HC group as composite tests 
for the NVI varied for children aged 6 years and those aged 7 years; specifically, Conceptual 
Thinking was only administered to children aged 6 years. 
bData unavailable for 6 children in the PME group and 2 children in the HC group as composite test 
for the NVI varied for children aged 6 years and those aged 7 years; specifically, Block Counting was 
only administered to children aged 7 years. 
cThe assumption of normality was violated, so the Mann-Whitney U test was used 
Similar trends as for the whole sample were observed for most of the cognitive 
outcome variables. That is to say, participants in the PME group performed significantly 
more poorly than those in the control group on most cognitive tests. However, between-group 
differences on the following variables were no longer significant at the corrected p-value (p 
= .003): KABC-II Block Counting, Beery Visual Perception Test, and the GPT insertion time 
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for the dominant hand. The aforementioned variables neared significance within the 95% 
confidence interval (i.e., ranging from p = .006 to p = .04). There were no significant 
between-group differences only for the Beery VMI scores in this sub-sample.  
Independent Component Analysis outcomes. Based on a comparison with the 
standard resting state networks (RSNs) identified in previous work (Beckmann et al., 2005; 
Bressler & Menon, 2010; Damoiseaux et al., 2006; De Luca, Beckmann, De Stefano, 
Matthews, & Smith, 2006), two raters (MK and JI) visually identified 14 3D spatial map
output components from the 35-component ICA as being artifactual, and potentially with a 
vascular and/or motion-related origin. By consensus, the raters identified the remaining 21 
components as potentially functionally relevant, though a number likely consisted of a 
mixture of RSNs and artifactual sources. To reduce the possibility of spurious results, the 
raters only considered the components classified as RSNs that were potentially relevant to 
PME exposure (as guided by literature). I describe these below, with Brodmann areas (BA) 
presented in parentheses (see Figure 4): 
1. Visual network (see Figure 4a): incorporating, bilaterally, the lingual gyrus (BA
18), cuneus (BA 7, 17, 18, 19), and precuneus (BA 31). 
2. Sensorimotor network (see Figure 4b): incorporating, bilaterally, the inferior frontal
gyrus, medial frontal gyrus, pre-central gyrus (BA 3, 4), paracentral lobule (BA 31), post-
central gyrus extending into the precuneus (BA 7), superior temporal gyrus (BA 41), the 
posterior aspect of insula (BA 13), and the left thalamus. 
3. Basal ganglia network (see Figure 4c): incorporating, bilaterally, the thalamus,
lentiform nucleus, putamen, caudate nucleus, pulvinar, lateral globus pallidus, nucleus 





   Figure 4. RSNs of interest identified in the 35-component ICA: (a) visual network; (b) sensorimotor network; (c) basal ganglia 
   network; (d) visuo-spatial network; (e) dorsal attention network; (f) fronto-parietal/central executive network. The coordinates  
   refer to millimeter distances from the anterior commissure. Images are shown in radiological convention.
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4. Visuospatial (occipitoparietal) network (see Figure 4d): incorporating, bilaterally,
the inferior temporal gyrus (BA 22), middle occipital gyrus (BA 19), extending into the 
cuneus, and the superior parietal lobule (BA 7). 
5. Dorsal attention network (see Figure 4e): incorporating, bilaterally, the post-central
gyrus (BA 3, 2), precentral gyrus (BA 6), inferior parietal lobule (BA 40), superior parietal 
lobule, and the middle occipital gyrus (BA 19).  
6. Fronto-parietal (central executive control) network (see Figure 4f): incorporating,
bilaterally, the middle frontal gyrus (BA 9, 46), inferior frontal gyrus, inferior parietal lobule 
(BA 40), superior parietal lobule, and the medial frontal gyrus (BA 8). 
Testing for between-group differences in motion. In addition to correcting data for 
motion (see complete description in the Methods section), the raters performed a between-
group comparison to test for any potential remaining systematic group differences in motion. 
An independent samples t-test revealed no significant effect for motion, t(23) = -1.26, p = .22. 
However, on average, participants in the PME group experienced greater motion (M = 0.16, 
SD = 0.12) than those in the control group (M = 0.11, SD = 0.08). Because head motion can 
change the results of resting state functional connectivity (Power, Barnes, Snyder, Schlaggar, 
& Petersen, 2012), the raters included motion as a covariate in the design matrix in order to
reduce systematic sources of error variance. 
Examining between-group differences in network connectivity. The raters identified 
significant between-group differences for two of the above-mentioned RSNs of interest. In 
the group contrast for the sensorimotor network, participants in the PME group showed 
increased network functional connectivity (p < .05) in a single voxel in the right post-central 
gyrus (see Table 18 and Figure 5a). In the group contrast for the basal ganglia network, 
decreased connectivity for participants in the PME group was observed in two clusters: the 
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right posterior cingulate gyrus (BA 31), extending into the precuneus, and the right inferior 
parietal cortex (BA 40; see Table 18 and Figure 5b).  
Visual inspection of these clusters suggested they form part of the posterior default 
mode network (DMN; Greicius et al., 2003) identified in this sample across all participants 
(and not initially included as one of the six RSNs of interest). This interpretation was 
confirmed by overlaying a component corresponding to the posterior DMN, thresholded at Z 
= 3, onto the cluster map (see Figure 5b). No further between-group differences were 
observed in any of the remaining four RSNs of interest at the 95% confidence interval. Of 
note here is that the between-group comparisons were corrected on a voxel-wise level, but 
not for comparisons across networks, due to concerns regarding the limited power (given the 
small sample size) of these comparisons. 
Table 18  
Clusters Differing in Connectivity Between Groups for RSNs of Interest (N = 23) 





Primary peak location 
(x, y, z) 
PME > Controls
R post-central gyrusa Sensorimotor 1 .04 31.5, -31.5, 43 
Controls > PME
R posterior cingulate gyrusa Basal Ganglia 12 .02 10.5, -43.5, 37 
R inferior parietal cortexa Basal Ganglia 10 .03 40.5, -52.5, 49 
R post-central gyrusa DMN 1 .04 34.5, -25.5, 46 
R pre-central gyrusb DMN 13 .05 31.5, -10.5, 61 
R caudate nucleusb DMN 20 .06 19.5, 1.5, 19 
R anterior cingulate cortexb DMN  18 .07 19.5, 25.5, 16 
Note. PME = prenatal methamphetamine exposure; R = right.
aHeight and extent thresholds of p < .05 were used to determine significant clusters. 
bHeight and extent thresholds of p < .10 were used to determine significant clusters as part of the post-
hoc analysis. 
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Figure 5. Significant between-group differences identified in the RSNs of interest: (a) Increased 
sensorimotor network connectivity in the right post-central gyrus in the PME group. (b) Decreased 
DMN connectivity in the right posterior cingulate gyrus (planes X and Y), and the right inferior 
parietal cortex (plane Z). R = right; L = left. 
85 
Because the clusters identified in the right posterior cingulate gyrus and right inferior 
parietal cortex were thought to form part of the DMN, a post-hoc between-group contrast was 
run for this network. Although the aforementioned findings were not replicated, a single 
cluster of decreased connectivity in the right post-central gyrus (closely located to the cluster 
of increased connectivity in the sensorimotor network in the initial analysis) was observed in 
the PME group (see Table 18 and Figure 6a). As the second cluster identified in the right 
post-central gyrus forms part of the sensorimotor network, this finding of decreased 
connectivity in the PME group suggests compromised connectivity between the sensorimotor 
network and the DMN in methamphetamine-exposed children.  
To further characterize group differences in DMN connectivity, clusters of at least 10 
voxels were identified that differed at the group level at a less stringent alpha of 0.1 (see 
Table 18). Using the lowered threshold, the raters identified three clusters of decreased 
connectivity in the PME group: the right precentral gyrus (BA 6, which forms part of the 
sensorimotor network [Mayka, Corcos, Leurgans, & Vaillancourt, 2006]; see Table 18 and
Figure 6b), the right caudate nucleus (which forms part of the basal ganglia network 
[Robinson et al., 2009]; see Table 18 and Figure 6c), and the right anterior cingulate cortex 
(which forms part of the salience network [Menon & Uddin, 2010]; see Table 18 and Figure 
6d). 
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Figure 6. Significant between-group differences for the DMN revealing decreased connectivity for the PME group in the following areas: 
(a) right post-central gyrus (sensorimotor network used as underlay); (b) right pre-central gyrus (sensorimotor network used as underlay);
(c) right caudate nucleus (basal ganglia network uses as underlay); (d) right anterior cingulate cortex (salience network used as underlay).
87 
Discussion 
The primary aim of this study was to determine whether cognitive functioning is 
impaired in children with a history of prenatal methamphetamine exposure (PME). The 
secondary aim, relating to the resting-state component of this study, was two-fold: (a) to 
identify intrinsic functional networks in children with a history of PME, and (b) to determine 
whether intrinsic functional connectivity within and between these networks might be 
compromised in children with PME. This study is the first of its kind to examine functional 
resting-state connectivity in this population, and as such that component of the study is 
properly regarded exploratory. 
In this section, I discuss the outcomes of each hypothesis within the context of 
relevant, previously published literature. The section begins with a discussion of the results of 
the between-group analyses (i.e., those relating to Hypothesis 1), and the findings from the 
regression-based analyses that assessed the association between PME and performance on 
neuropsychological tasks when potentially confounding variables were controlled for (i.e., 
Hypothesis 2). I then discuss the results from the Independent Component Analysis (ICA) 
that examined the between-group differences in intrinsic functional connectivity resulting 
from PME (i.e., Hypothesis 3). Lastly, I address the limitations of this study, suggest 
directions for future research, and comment on the clinical significance of the results reported. 
Impaired Cognitive Functioning in Children with PME 
Hypothesis 1. The prediction was that, compared to controls, children with PME 
would perform significantly more poorly on measures of general intellectual functioning, 
memory, language, and visual-motor integration and fine motor co-ordination. This 





General intellectual functioning. Overall, the current findings of lower scores on the 
KABC-II Non-Verbal Index (an IQ equivalent) in the PME group are largely consistent with 
previous studies that have documented poor performance on both IQ measures and parent-
rated cognitive problem subscales in children with PME (Billing et al., 1998; Cernerud et al. 
1996; Chang et al., 2004; Diaz et al., 2014). Specifically, Chang et al. (2004) found a trend 
for lower verbal IQ scores on both the Wechsler Intelligence Scale for Children (WISC) and 
the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) in a group of 3-15 year 
old children with PME. More recently, Diaz et al. (2014) found increased cognitive problem 
scores in the PME group, aged 7.5 years, as assessed by Conners' Parent Rating Scale 
(CPRS).  
Despite the apparent consistency between parent-rated and formally assessed 
cognitive problems reported in children with PME, IQ scores and indirect measures are crude 
indicators of cognitive functioning, and so may not provide sufficient insight into the nature 
of the cognitive deficits observed in children with PME. Although the current study did make 
use of a comprehensive cognitive battery, qualitative observations of the participants with 
PME in the current study (specifically, I noted general distractibility and difficulties in 
sustaining attention in exposed participants) warrant further investigation. More data on the 
affective, behavioral, attentional, and executive profiles of children with PME are needed in 
order to make meaningful interpretations regarding the lower IQ scores reported in the 
current study.  
Accumulating evidence suggests a relationship between intelligence tests and 
measures of executive functioning (Ardila, Pineda, & Rosselli, 2000; Arffa, 2007; Friedman 
et al., 2006). Although the NVI is not a discrete measure of executive functioning, children 
with PME performed significantly worse across all measures of sequential and simultaneous 
processing, as well as measures of planning ability – all of which rely on aspects of executive 
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functioning (specifically, attention, planning, problem solving, self-monitoring, and mental 
flexibility; Anderson, 2001).  
A small number of studies have explored the profile of executive deficits in children 
with PME. For example, Piper et al. (2011) observed pronounced deficits in executive 
functioning and mild impairments in spatial memory, suggestive of a selective profile of 
abnormalities in a sample of similar age to the present study. Furthermore, the four-fold 
incidence rate of attention-deficit/hyperactivity disorder (ADHD) diagnosis in children with 
PME (compared to controls), as reported by Piper et al., suggests that children with PME 
may be predisposed to a unique profile of executive dysfunction which may mediate 
performance on other cognitive measures. A study by Derauf et al. (2012a) supports this 
claim, proposing deficits in executive functioning related to inhibitory control in children 
with PME at 5.5 years of age. 
Typically, deficits in executive functioning have been associated with behavioral 
changes such as distractibility, impulsivity, disinhibition, hyperactivity, social problems, and 
communication difficulties (Clark, Prior, & Kinsella, 2002; Semrud-Clikeman, Walkowiak, 
Wilkinson, & Butcher, 2010; Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). In 
relation to PME research, the IDEAL study found increased emotional reactivity, and 
anxious/depressed problems, at the age of 3-5 years, externalizing and ADHD problems at 
the age of 5 years (LaGasse et al., 2011), subtle differences in outcomes predictive of ADHD 
at 5.5 years (Kiblawi et al., 2013), and neurobehavioral disinhibition at 5 and 6.5 years of age 
(Abar et al., 2013b). It is therefore possible that existing research on the cognitive, affective, 
and behavioral outcomes in children with PME might be parsimoniously explained by 
considering deficits in executive functioning.  
Despite a poor understanding of the etiology of the lower IQ scores reported in the 
current study, structural imaging studies provide evidence for a distinct neural basis for the 
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lowered IQ scores in children with PME. For example, volumetric reductions in the caudate 
nucleus in preschool children with PME have been significantly correlated with reduced 
cognitive control processes and lower IQ scores (Derauf et al., 2012b; Sowell et al., 2010). 
Although the consistency of these findings has not yet been established across many studies, 
the structural abnormalities reported above are functionally related to some of the deficits 
reported in children with PME in both the current and other studies. Furthermore, the 
structural findings shed light on the resting state data analyzed for the current study. 
Learning and memory. Children in the PME group performed significantly more 
poorly than healthy controls on a task of visual-verbal associative learning (the KABC-II 
Atlantis subtest), as well as on the delayed recall component of that task (the KABC-II 
Atlantis Delayed subtest). This finding is consistent with research suggesting that structural 
and metabolic changes in striatal structures associated with MA use may be linked to 
abnormalities in verbal and visual memory in both prenatally exposed children (Chang et al., 
2004) and adult MA users (Chang et al., 2007). For example, Change et al. (2004) found that 
decreased putamen, globus pallidus, and hippocampal volumes were significantly correlated 
with decreased performance on sustained attention and delayed verbal memory tasks, which 
may contribute to poor learning in children with PME (Chang et al., 2004). 
Furthermore, the observed impairments in learning and delayed recall performance of 
children with PME are also consistent with the finding of decreased connectivity in the basal 
ganglia RSN observed in the current sample (discussed below, under Disrupted Functional 
Connectivity in Children with PME). Together, these findings have significant clinical 
implications. Because of the association between basal ganglia and executive functioning, 
structural abnormalities in the basal ganglia in children with PME might be functionally 
related to impairments in executive functioning, including impairments in learning ability 
(i.e., Derauf et al., 2012b; Roussotte et al., 2011). 
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Language. Confrontation naming ability (assessed by the BNT-SA-SF) was 
significantly impaired in children with PME. Chang et al. (2004) reported similar results in a 
group of 3-15-year-old children with PME whose performance on the Expressive One Word 
Picture Vocabulary Test was compared to that of an age-matched healthy control group. This 
finding was not replicated in a younger cohort, however (Chang et al., 2009).  
A potential hypothesis for the naming deficit reported in some (but not all) children 
with PME is that the reduced bilateral hippocampal volumes identified by Chang et al. (2004) 
may be linked to reduced learning and encoding capacities, and may thereby affect 
confrontation naming ability (Lavenex & Lavenex, 2013). Intact confrontation naming ability 
depends on the integrity of the hippocampus and of the connecting frontotemporal networks 
(Bonelli et al., 2011). Hence, it might be useful for future studies to employ more extensive 
language and memory batteries to establish whether a specific naming deficit exists in 
children with PME, and, if so, whether it is attributable to a semantic memory deficit or to a 
retrieval deficit (i.e., a deficit related to executive dyscontrol of memory processes). 
Visual-motor integration. In the current study, children in the PME group performed 
significantly more poorly than healthy controls on the Beery Visual and Motor subtests (and 
results neared significance on the Beery VMI measure), suggesting compromised visual 
sensory input, motor output, and their integration. These observations are consistent with 
reports from previous studies that used the same measure (Chang et al., 2004, 2009; Colby et 
al., 2012). 
In adult MA users, the striatum, which contains the highest density of dopaminergic 
synapses, appears particularly vulnerable to the effects of MA (Chang et al., 2007). Because 
the dopaminergic system regulates motor pathways and cognitive functions that require 
attention, it is possible that children with PME may show similar deficits to those observed in 
adult users (including psychomotor slowing; see Salo et al., 2007, 2009; Scott et al., 2007). 
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This hypothesis has been partly corroborated by studies showing that structural and metabolic 
striatal abnormalities are associated with poor performance on tasks of visuomotor 
integration in both young cohorts (average age = 4 years; Chang et al., 2009) as well as 
school-aged children with PME (average age = 8 years; Chang et al., 2004). Furthermore, 
these findings suggest that early difficulties in visuomotor integration in children with PME 
may persist into later childhood.  
Fine motor co-ordination. Consistent with the current findings, reported above, of 
poor visuomotor integration, children in the PME group showed significantly reduced speed 
on a task of fine motor co-ordination and dexterity (i.e., the Grooved Pegboard Test, using 
both dominant and non-dominant hands). These findings of compromised motor functioning 
are consistent with previous literature on prenatally MA-exposed children throughout 
childhood development. For instance, some studies report hypotonia in the newborn period 
(LaGasse et al., 2010; Smith et al., 2008), and others report poorer performance on tasks 
measuring physical fitness and activities by age 14 years (Cernerud et al., 1996). 
Data from structural and metabolic neuroimaging studies provide evidence for a 
distinct neural basis for the above-mentioned deficits. Specifically, Chang et al. (2004) found 
that poorer visuomotor integration, as measured by the Beery VMI, was associated with 
smaller globus pallidus volumes in school-aged children with PME. A subsequent study by 
the same group revealed that lower thalamic myoinositol levels were associated with poorer 
visuomotor performance in children, aged 3-4 years, with PME (Chang et al., 2009). The 
globus pallidus is responsible for mediating increases and decreases in excitatory thalamic 
input to the motor cortex by way of direct and indirect pathways, respectively (Desmurget & 
Turner, 2010). Therefore, it is possible that reduced globus pallidus volumes and altered 
metabolic activity in the thalamus of children with PME contribute to poor performance on 
tasks of motor control. 
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Similar neuroimaging findings have been reported in adult MA users. Chang et al. 
(2005) found enlarged striatal (putamen and globus pallidus) volumes in adults who recently 
abstained from MA use. However, those with greater cumulative MA use, or longer duration 
of use, had smaller striatal volumes (as observed in most studies of PME). These reduced 
striatal volumes were associated with poorer performance on a measure of fine motor co-
ordination (specifically, the GPT).  
Relationship between PME and Neuropsychological Outcomes when Controlling for 
Potential Confounding variables 
To determine whether PME is a primary mechanism underlying cognitive 
impairments described in the present sample, it was necessary to consider the potentially 
confounding contribution of child and maternal sociodemographic and anthropometric 
variables to the observed between-group differences (Jacobson & Jacobson, 2005). 
Hypothesis 2. The prediction was that the cognitive deficits observed in the PME 
group would be related to the effects of PME, and not to the effects of potential confounding 
variables (viz., child‟s age at testing, child‟s weight at testing, maternal level of education, 
and maternal alcohol exposure). This prediction was partially confirmed using 15 separate 
hierarchical regression models. Child‟s weight at testing and maternal alcohol exposure were 
found to have no significant predictive value for the cognitive outcomes assessed. Below, I 
discuss only the potential confounding variables that were found to be significant predictors 
of some of the cognitive outcomes investigated in the current study. 
Child’s age at testing. Child‟s age at testing had a significant effect on one of the 
KABC-II simultaneous processing subtests (Conceptual Thinking). However, this subtest was 
only administered to 6-year-olds (the Block Counting subtest was administered as the age-




making meaningful interpretations of these results problematic. Furthermore, because of the 
age-specific cut-off for this subtest, the sample size used in modeling was quite small, thus 
further compromising the reliability of results.  
Child‟s age at testing was also a significant predictor of one of the KABC-II planning 
ability subtests (Story Completion). However, it was only a significant predictor of 
performance on that subtest after group status was entered into the regression model. Given 
that children in the PME group were significantly younger than those in the control group, it 
is possible that children in the PME group performed more poorly not only because of their 
exposure to the drug, but also due to relatively immature development. Cognitive control 
develops gradually over childhood, and improvements in control across development make 
an important contribution to the kinds of higher cognitive function measured by, for instance, 
tests of planning ability (Bunge, Dudukovic, Thomason, Vaidya, & Gabrieli, 2002). 
Finally, child‟s age at testing was the sole predictor of performance on the Beery VMI, 
and remained significant even after group status was entered into the regression model. 
Child‟s age at testing was not, however, a significant predictor of performance on either the 
Beery Visual or Beery Motor subtests (administered consecutively after the Beery VMI). It is 
likely that the Beery VMI (which integrates both the visual and motor aspects of the test) was 
more cognitively challenging than either the Beery Visual or Motor subtests, and therefore 
performance on the Beery VMI improved with age. 
Overall, then, child‟s age at testing was the sole predictor of performance on only one 
measure: the Beery VMI. However, given the known effects of age on cognitive performance 
(Allaire & Marsiske, 1999; Bunge et al., 2002; Jones, Rothbart, & Posner, 2003), it remains 
an important factor to consider when interpreting data from studies such as this. 
Maternal level of education. Given the proposed relationship between maternal level 
of education and socioeconomic status (SES; Luo, Wilkins, & Kramer, 2006), and the well-
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established association between SES and cognitive ability and achievement in childhood 
(Hackman & Farah, 2009; Noble, McCandliss, & Farah, 2007), I investigated maternal level 
of education as a potential confounder of the relationship between group status and cognitive 
performance.  
Consistent with existing research documenting the effects of lower SES environments 
and maternal level of education on child IQ and cognitive development (e.g., Kalil, Ryan, & 
Corey, 2012; Voss, Jungmann, Wachtendorf, & Neubauer, 2012), maternal level of education 
was a significant predictor of KABC-II NVI scores. Specifically, maternal level of education 
was a significant predictor of performance on some of the subtests which constitute the 
KABC-II NVI, including sequential processing (the Hand Movements subtest) and planning 
ability (the Pattern Reasoning subtest), as well as learning ability (the Atlantis subtest, a 
KABC-II measure independent of the NVI).  
Recent research suggests that low SES is associated with various neurocognitive 
impairments differentially, with language and executive/attentional domains being most 
vulnerable to such effects (see Hackman & Farah, 2009, for a review). Although maternal 
level of education was not a sole predictor of any one cognitive outcome in the current study, 
it remains a significant potential confounder and should be considered when interpreting the 
effects of PME on cognitive outcomes. This is particularly true for the current sample, as the 
mothers in the control group, on average, had a higher level of maternal education than those 
in the PME group. 
Disrupted Functional Connectivity in Children with PME 
Hypothesis 3. The prediction was that children with PME would show disrupted 
functional connectivity in frontal cortical, visuomotor, and striatal networks when compared 
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to typically developing, demographically-matched controls. This prediction was partially 
confirmed using independent components analysis.  
Overall, the present results suggest that, in the sub-group of children with PME for 
whom imaging data were available, there is evidence for compromised connectivity within 
and between the basal ganglia and default mode network (DMN) networks. It is important to 
note that this was an exploratory analysis and that, therefore, the resting state networks 
(RSNs) selected for the between-group analysis were chosen according to available 
knowledge on the behavioral and cognitive pathology of PME. In particular, 
methamphetamine exposure, in both adult and prenatally-exposed populations, has been 
linked to deficits in areas of the brain responsible for the regulation of attention, memory, 
visuomotor integration, and executive functioning, all of which rely on aspects of the six 
networks originally selected (i.e., the visual network, the sensorimotor network, the basal 
ganglia network, the visuospatial network, the dorsal attention network, and the central 
executive network). The DMN, although included in the post-hoc analysis, was not chosen as 
one of the original six RSNs because of considerations related to statistical power. For the 
sake of brevity, below I discuss only the RSNs for which the analyses detected significant 
between-group alterations in functional connectivity. 
Basal ganglia network. Children with PME showed relatively reduced functional 
connectivity in two regions for the between-group basal ganglia network analysis, when 
compared to controls: the right posterior cingulate gyrus and the right inferior parietal cortex. 
Of note here is that, traditionally, these regions are not associated with the basal ganglia 
network; rather, they constitute aspects of the default mode network (DMN; Fransson & 
Marrelec, 2008; Greicius, Supekar, Menon, & Dougherty, 2009), and hence will be discussed 
in the sub-section that follows.  
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Given the above findings of reduced connectivity in areas typically associated with 
the DMN (for the between-group basal ganglia analysis), a post-hoc between-group ICA 
analysis was run on the DMN. A region of decreased connectivity was observed in the right 
caudate nucleus (CN) of the PME group, which traditionally forms part of the basal ganglia 
network. The CN provides input to the oculomotor, dorsolateral prefrontal, and lateral 
orbitofrontal circuits. Hence, it plays a role in reward, emotional, and cognitive regulation 
(Haruno et al., 2004; Robinson et al., 2009).  
Consistent with the present findings, Roussotte et al. (2012) found decreased 
functional connectivity between the right dorsal caudate and most prefrontal areas during 
working memory tasks in children with PME (aged 7-15 years). As mentioned earlier, 
volumetric reductions in the caudate nucleus have also been significantly correlated with 
reduced cognitive control processes in preschool children with PME (Derauf et al., 2012b) 
and with lower full-scale IQ scores in school-aged children with PME (Sowell et al., 2010). 
The current findings are also consistent with literature on the effects of adult 
methamphetamine use. For example, Lee et al. (2009) found that reduced striatal dopamine 
receptor availability in the caudate nucleus was associated with increased impulsivity in MA-
dependent adults.  
It is plausible that a similar mechanism (i.e., reduced dopaminergic receptor 
availability due to PME in the caudate nucleus) contributes to the decreased connectivity 
found in the right caudate of the PME group in the present study. Furthermore, because 
decreased connectivity in the right caudate of the PME group was found in the between-
group DMN analysis, this suggests compromised connectivity within and between the 
caudate nucleus (which is part of the basal ganglia network) and DMN.  
Cumulatively, the MA-associated structural, metabolic, and functional brain changes 
in the striatum, as observed in both adults and prenatally exposed children, suggest the 
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potential for circuit-level alterations in the mesocorticoclimbic system. The consequences of 
such alterations have been linked to disruptions in cognitive, emotional, and reward 
regulation mechanisms (for a review see Sutherland, McHugh, Pariyadath, & Stein, 2012).  
Default mode network. Participants in the PME group displayed decreased functional 
connectivity in the right posterior cingulate cortex (PCC) and right inferior parietal cortex 
(IPC) for the between-group basal ganglia network analysis. The aforementioned regions 
constitute the posterior DMN (Fransson & Marrelec, 2008). The DMN is typically associated 
with self-related and social cognitive processes, value-based decision making, and emotion 
regulation (Buckner, Andrew, Hanna, & Schacter, 2008). These affective and cognitive 
aspects of functioning have not yet been explored in detail in children with PME.  
The PCC, a significant component of the DMN, plays a pivotal role in how intrinsic 
activity is mediated throughout the DMN (Fransson & Marrelec, 2008). Neuroimaging 
studies have implicated the PCC in a range of cognitive tasks that draw on various aspects of 
self-processing (i.e., self-reflection tasks, autobiographical memory tasks, emotional and 
moral judgment tasks; for reviews, see Buckner & Carroll, 2007; Cravanna & Trimle, 2006; 
Northoff & Bermpohl, 2004). Moreover, previous imaging studies in adult MA users have 
observed metabolic and volumetric changes in the PCC that are associated with higher levels 
of depression, anxiety, and aggression (London et al., 2004; Sekine et al., 2006). Increased 
PCC activation has also been associated with a choice of delayed reward rather than 
immediate reward choices in healthy controls (Wittmann, Leland, & Paulus, 2007). This 
piece of data suggests another potential mechanism for the increased inattention and 
impulsivity reported in children with PME (Chang et al., 2004; Kiblawi et al., 2013).  
The right IPC has bidirectional connections to the right dorsolateral prefrontal and 
anterior cortex, and has been linked to the visuospatial orienting of attention and several 
aspects of decision-making, including: sustained and selective attention, switching from task-
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relevant to global targets, voluntary attentional control, as well as the distinction between task 
irrelevant and task-relevant events (Ciaramelli, Grady, & Moscovitch, 2008; Naghavi & 
Nyberg, 2005). Therefore, the right IPC may be critical for the extraction and selection of 
task-relevant information, and it has been implicated in inhibitory control in several different 
paradigms (Garavan, Ross, & Stein, 1999; Kana, Keller, Minshew, & Just, 2007).  
Moreover, an RS-fMRI study found that decreased activation in the right IPC (as well 
as in the dorsolateral prefrontal and temporal cortex, and in the insula) significantly predicted 
relapse rates in MA-dependent adults, thus further supporting the hypothesis that MA affects 
a network of structures that are critical for decision-making (Paulus, Tapert, & Schuckit, 
2005). How these reductions in functional connectivity manifest at an affective, behavioral, 
or cognitive level in prenatally-exposed populations is not yet clear, however.  
Salience network. Participants in the PME group displayed, relative to the control 
group, decreased functional connectivity, at a more lenient statistical threshold (p < .10), in 
the anterior cingulate cortex (ACC) for the DMN analysis. The ACC traditionally forms part 
of the salience network (Seely et al., 2007). This network is anchored by the paralimbic 
anterior cingulate and frontoinsular cortices, and has extensive connections to subcortical and 
limbic structures. The salience network connects areas in the brain responsible for conflict 
monitoring, reward-processing, and interoceptive-autonomic functioning.  
The ACC itself plays a role in the processing of errors and conflict (Kerns et al., 
2004), and is part of the attentional network previously shown to be deficient in children with 
PME (Chang et al., 2004). The ACC also has robust connections with dopamine-rich striatal, 
medial temporal, and thalamic structures, all shown to be dysmorphic in children with 
prenatal drug exposure (Roussotte et al., 2011). In MA-dependent adults, reduced levels of 
N-acteyl-asparate, a marker for living neurons, have been reported in the cingulate (Nordahl




(London et al., 2004), cerebral blood flow (Hwang et al., 2006), gray matter density 
(Thompson et al., 2004), and decision-making related to activation in the ACC in MA-
abusing or -dependent adults (Paulus, Hozack, Frank, Brown, & Schuckit, 2003). 
Although functional imaging research on children with PME is limited, and the results 
of extant studies somewhat inconsistent (e.g., Chang et al. [2004] found volumetric 
reductions in the ACC, whereas Sowell et al. [2011] found volumetric increases in the ACC), 
the abnormalities reported in striatal regions are largely consistent with MA‟s neurotoxic 
effect on dopaminergic neurons, which, in humans, innervate the ACC more densely than any 
other cortical structure (Paus, 2001). Furthermore, in light of (a) the observation of decreased 
connectivity in the right IPC, and (b) the fact that inferior parietal regions, in conjunction 
with co-activation with the ACC, have been related to error detection, response conflict, and 
visuospatial alerting and orientating (evidenced in healthy controls; Kana et al., 2007), one 
might suggest that synchronized connectivity between these two regions may be reduced in 
children with PME.  
Sensorimotor network. In the initial group contrast for the sensorimotor network, the 
analysis detected a voxel-sized increase in functional connectivity in the post-central gyrus 
(i.e., the primary sensory cortex) for the PME group. Naturally, the interpretive value of this 
finding is limited due to the size of this cluster. Furthermore, a post-hoc contrast for the 
DMN revealed decreased connectivity in the right post-central gyrus (also 1 voxel in size). 
The latter analysis also revealed a larger area of decreased connectivity in the pre-central 
gyrus (i.e., the primary motor cortex) for the PME group at a less stringent statistical 
threshold (p < .10). The pre-central gyrus and post-central gyrus make up part of the 
sensorimotor RSN (Mayka et al., 2006; Smith et al, 2009); therefore, the finding of reduced 
connectivity in those regions suggests compromised connectivity within and between the 
DMN and sensorimotor network.  
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To date, no studies have documented metabolic or structural changes in the primary 
sensory and motor areas in children with PME. However, Chang et al. (2009b) found altered 
neurometabolites in the frontal white matter and thalamus of children with PME. These 
alterations were correlated to deficits in visuomotor integration. These findings suggest that 
PME may alter motor or psychomotor neurodevelopment via the frontostriatal or 
thalamocortical pathways. It is possible that the reductions in functional connectivity in the 
primary sensory and motor cortices relate to altered white matter integrity (and thereby, 
communication with cortical areas) in children with PME (Cloak et al., 2009b; Colby et al., 
2012). Alternatively, these findings suggest localized cortical abnormalities in the primary 
motor and sensory cortex due to dopamine transporter reductions (Volkow et al., 2001). 
Evidence from research on the dopaminergic modulation of cortical function in patients with 
Parkinson‟s disease supports the latter hypothesis. That research reports increased activation 
in the right primary motor cortex after dopaminergic therapy (Mattay et al., 2002). 
Interim summary. Taken together, the results of the between-group basal ganglia 
and DMN analysis suggest compromised connectivity within and between the two networks. 
Although there are no previously published RS-FMRI data for children with PME, the results 
of this study are largely consistent with the hypothesis that PME (a) affects the neurotropic 
roles of monoaminergic transmitters (particularly DA), and (b) leads to morphologic and 
metabolic alterations in several brain structures, particularly those constituting the striatum 
(Frost & Cadet, 2000). Although the hypotheses provided in this subsection are largely 
speculative, given the known functional disturbances associated with disruptions in 
frontostriatal circuitry (i.e., impaired capacity for self-regulatory control, decision-making 
and executive dysfunction; Caset, 2001; Chudasama & Robbins, 2006; Scott et al., 2007; Wu, 
Gau, Lo, & Tseng, 2014), the evidence provided by this study is generally consistent with 




Limitations and Directions for Future Research 
Several limitations of this study should be addressed by future research aiming to 
further delineate the structural and functional brain changes that might result from PME. 
Many of these limitations relate to issues discussed earlier, in the section titled Challenges in 
Prenatal Drug Exposure Research; however, although these limitations might have been 
anticipated, they were, for practical reasons, difficult to overcome. 
The primary limitation of this study is that PME histories and dosages were generally 
unavailable given that many participants in the exposed group were being cared for by family 
members or foster care parents. Furthermore, even in instances where the birth mother was 
present, the retrospective data was limited to „yes/no‟ responses related to MA use. Hence, 
specific data pertaining to the period, duration, and frequency of MA use throughout 
pregnancy were largely unavailable. This is true of most retrospective studies of prenatal 
drug exposure given difficulties in accurately recalling drug histories years after use, a 
difficulty further compounded by the stigma of admitting to drug use during pregnancy 
(Kaltenbach & Finnegan, 1993).  
The second major limitation of this study involves the issue of polydrug exposure. 
More than one-third of the subjects with PME also had concomitant prenatal alcohol 
exposure. Although alcohol exposure was controlled for in the regression analysis in an 
attempt to describe the effects of PME more accurately, it is possible that higher-order 
interaction effects between alcohol and PME may account for some of the cognitive and 
resting state outcomes observed in this sample. Furthermore, even though maternal smoking 
status was indirectly controlled for (i.e., all the mothers in the exposed group who drank 
alcohol also smoked), nicotine exposure might also have contributed uniquely to the observed 
differences between the PME and control groups. For instance, there is some evidence that 
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striatal volumetric reductions in MA-dependent adults may be a consequence of nicotine 
exposure (Morales, Lee, Hellemann, O‟Neill, & London, 2012) 
In addition to the potential confounding variables controlled for in this study, it is 
possible that other unaccounted-for variables (e.g., emotional trauma and abuse, neglect, 
multiple family placements, or differing parenting styles) may have contributed to the 
observed results (Davies & Bledsoe, 2005). For example, a high prevalence of depressive 
symptoms in MA-using mothers has been associated with neonatal effects, including 
decreased arousal and increased stress in infants with PME (Paz et al., 2009). Therefore, high 
levels of PME may impact directly (or indirectly, via the effects of maternal depression) on 
neurological development in affected children. Given that this study is part of a larger 
research program with a prospective longitudinal design, future investigations ought to 
consider the possible impact of psychiatric comorbidities (diagnosed via formal assessment) 
both within the maternal sample (e.g., post-natal depression) and within the group of exposed 
participants (e.g., ADHD). Although in the current study general psychiatric and medical 
comorbidities were screened for using self-report health-status questionnaires, given the low-
SES background of the participants (and thereby limited access to regular medical and mental 
health care), it is possible that they have been undetected (Moultrie & Kleinthies, 2006). 
In terms of the study design, retrospective human studies of prenatal drug exposure 
are not ideal for isolating the effects of PME (unlike animal studies, which allow for better 
control over experimental conditions). Nevertheless, studying „pure‟ single-drug exposure 
might compromise the clinical relevance and ecological validity of PME studies. Therefore, it 
is important that future studies recruit larger samples in order to better isolate the specific 
affective, behavioral, and cognitive effects of PME.  
A third major limitation of this study pertains to the interpretive value of the 
conclusions from the resting-state analysis. The exploratory nature of the study design and 
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the novelty of the presented data make meaningful interpretations problematic. Although 
resting state connectivity measures are reliable, even in children, the reliability varies 
depending on the preprocessing and data handling steps (Thomason et al., 2011; Zuo et al., 
2013). Given the small sub-sample employed for ICA analysis, between-group comparisons 
were corrected on a voxel-wise level, but not for comparisons across networks. Therefore, it 
is possible that no between-group differences in functional connectivity would have been 
observed if the effect of multiple comparisons had been accounted for. However, due to 
concerns relating to the small sample size (which may have precluded the detection of 
possible sub-threshold differences), the threshold for statistical significance when conducting 
the post-hoc DMN analysis was lowered (i.e., p < .10). Although this step does limit the 
extrapolative value of the results, the fact that the findings were generally consistent with 
previous literature on PME warrants further investigation. One of the advantages of RS-fMRI 
data is that it allows for the achievement of larger samples through the synthesis of multiple 
data sets. Future studies might want to employ more collaborative approaches in determining 
the relevance and reliability of changes in intrinsic functional connectivity in children with 
PME. 
The last major limitation relates to the known influence of in-scanner motion on 
resting-state connectivity (Satterthwaite et al., 2012). Increases in motion have been 
associated with both increases and decreases in intrinsic functional connectivity, depending 
on the RSN of interest. This concern was addressed by the implementation of motion 
correction, testing for between-group differences in motion (of which there were none), and 
eliminating data from participants who exceeded standard motion parameters. However, it is 
possible that the participants who displayed excessive motion (and whose datasets were 
therefore removed from the analysis) represent a unique subsample of children who may be 
more severely affected by PME. Given that I conducted no correlational analysis between the 
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RS outcomes and cognitive measures, one cannot assume that participants excluded from the 
RS-fMRI analysis were equally representative of the full sample in terms of differences in 
functional connectivity. Nevertheless, a secondary between-group analysis of the cognitive 
outcome data in the imaging sub-sample detected similar trends to the full sample (i.e., 
relatively poorer cognitive performance across most measures for the PME group), 
suggesting that the sub-sample may have been representative of the full sample.  
In summary, many of the limitations of this study relate to a lack of statistical power. 
Specifically, the small sample size limits the ability to account for many of the above-
mentioned potential confounding variables. However, given the profound neurotoxic effect of 
MA in both adult users and animal models, PME is a likely contributor to the observed 
between-group differences. 
Conclusion and Clinical Significance 
Evidence from the current study has contributed to, and is largely consistent with, 
previously published literature on PME exposure. The current study found that PME affects 
areas of the brain responsible for the regulation of domain-specific cognitive functions, 
including learning and memory, confrontation naming, visuomotor integration, and fine 
motor co-ordination. Furthermore, children with PME had lower IQ scores than 
demographically-matched controls. Although this finding is not consistent across studies, it 
warrants further investigation in light of the presented evidence suggesting deficits in the 
frontostriatal systems (i.e., attentional and inhibitory control systems). As argued earlier, it is 
possible that children with PME present with a unique profile of abnormalities in lower and 
higher-order aspects of attention, representative of executive dysfunction. Extended follow-
ups into late childhood, encompassing a broad number of outcome measures, might help 
elucidate the developmental trajectory of neuropsychological dysfunction in PME.  
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Despite the purely exploratory nature of the imaging component of this study (and, 
thereby, minimal assumptions of the dataset), the results suggest abnormal functional 
connectivity within and between the DMN and basal ganglia networks in children with PME. 
To date, RS-fMRI has been used in only a handful of addiction-related studies, and none have 
been conducted on children with PME. Although a few functional MRI studies have provided 
insights into the potential brain regions activated by particular tasks in children with PME, a 
systematic understanding of dysfunctional brain circuits has remained elusive. This is likely 
due to the variability in the locus of deficits identified in children with PME, as well as a 
general lack of consistency in the experimental paradigms used to investigate them. The 
RSNs explored in this study provide a useful framework through which alterations of 
functional connectivity in PME can be explored further. Specifically, follow-up correlational 
analysis (on larger samples) are needed to determine how the identified areas of decreased 
functional connectivity in children with PME relate to cognitive outcomes. 
Overall, the current data suggest that PME has a unique effect on cognitive 
performance and functional connectivity in a sample of South African children with PME, 
and that this effect largely withstands the effects of potentially confounding 
sociodemographic and anthropometric variables. These findings are important because they 
provide a novel contribution to the definition of neuropsychological profiles of children with 
PME. Additionally, the finding of cognitive impairments specific to children with PME (i.e., 
deficits present beyond the effects of comorbid maternal alcohol exposure), alongside 
preliminary data showing disruptions in intrinsic functional connectivity in a sub-sample of 
these children, supports the inclusion of targeted interventions into programs for children 
with a history of PME. 
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Mother / Principal caregiver details
1 Name of primary caregiver: 
2 Relationship of primary caregiver to 
child e.g. grandmother: 
3 Name of mother:  
4 Person answering questionnaire: 
5 Address of child:   
6 Contact details: a. Home no: _____________________________
b. Work no:  _____________________________
c. Cell: _________________________________
7 Date of birth of mother: 
_ _ / _ _ _ / _ _ _ _ 
 DD /  MMM /  YYYY
8 Ethnicity of mother (tick one): 
     African/Black      
     Asian 
     Caucasian/White     
     Coloured 
     Other; please specify 
_____________________________   
9 Highest level of education of 
mother (circle one): a. Primary school  1  2  3  4  5  6  7
High School  8   9  10  11  12
College / University 1  2  3  4  5  6  7  8
b. Total of a: _____
c. Diploma / Degree
obtained___________________________
10 Is the mother currently employed: 
     Yes   






Name her occupation: 
How long has she been at this job: 
Is she the “breadwinner”: 
How many hours does she work a 
week (tick one)? 
_____________________________________________ 
_____DD _____ MM _____ YY 
     Yes   
     No 
20 to 40 hours / week   
     40 to 60 hours / week  
60 to 80 hours / week
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15 Marital status (tick one): 
     Single      
     Married 
     Living with partner  
     Divorced 
     Separated 
     Widowed 
16 Household income per year of 
household where the child lives 
(tick one):   
     <R10 000      
     R10 000 - R20 000 
     R 20 000 - R40 000  
     R40 000 - R60 000 
     R60 000 - R100 000 
>R100 000
17 How many people live in the house 
where the child lives:   _______ people 
18 How many rooms are in the house 
where the child lives: _______ rooms 
19 Medical history of mother; any 
illnesses or conditions: 
20 Surgical history of mother; any 
operations (list, if any): 
21 Birth history/complications of 
mother (list, if any): 
22 Number of life siblings born: 
_______ 
23 Number of siblings still alive: 
_______ 
24 Was this a planned pregnancy: 
     Yes   




25 Full name: 
26 Date of birth: 
_ _ / _ _ _ / _ _ _ _ 




     Male   
     Female 
29 Level of education (grade): 
30 How long in school: a. Preschool: _____Y_____M
b. Primary school:   _____Y_____M






33 Head circumference (HC): 
______cm 
34 Upper arm circumference (UAC): 
______cm 
Birth details of child 
35 Gestation period: 
a. ______Weeks      b. ______Days
36 Birth weight: 
______g 
37 Apgar score: 
a. ______1 min      b. ______5 min
38 Length: 
______cm 
39 Head circumference: 
______cm 
40 Birth complications (list, if any): 
41 Operations / illnesses (list, birth to 
present, if any): 
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Drug Intake Questionnaire 
Methamphetamine and Alcohol Exposure Questionnaire 
42 Person answering questionnaire: 
43 Contact details of mother: 
(Preferably, the mother should answer the 
questions that follow i.e. Questions 44-59.) 
a. Home no: _____________________________
b. Work no:  _____________________________
c. Cell: _________________________________
44 How many months was the mother pregnant 
(according to the clinic records), when she 




FIRST TRIMESTER (0-12 weeks)     Tick the most appropriate answer.
45 Did you use any methamphetamine? 
(If “yes”, proceed to Question 46.   
If “no”, skip Question 46; continue with Question 47.) 
     Yes 
     No 
46 If yes, how many times did you use methamphetamine per 
week?  Once per week or less 
 Two to three times per week 
    Four to six times per week 
    Daily 
SECOND TRIMESTER (13-24 weeks)     Tick the most appropriate answer. 
47 Did you use any methamphetamine? 
(If “yes”, proceed to Question 48.   
If “no”, skip Question 48; continue with Question 49.) 
     Yes 
     No 
48 If yes, how many times did you use methamphetamine per 
week?  Once per week or less 
 Two to three times per week 
    Four to six times per week 
    Daily 
THIRD TRIMESTER (24-40 weeks)     Tick the most appropriate answer.
49 Did you use any methamphetamine? 
(If “yes”, proceed to Question 50.   
If “no”, skip Question 50; continue with Question 51.) 
     Yes 
     No 
50 If yes, how many times did you use methamphetamine per 
week?  Once per week or less 
 Two to three times per week 
    Four to six times per week 
    Daily 
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ALCOHOL EXPOSURE 
FIRST TRIMESTER (0-12 weeks)     Tick the most appropriate answer. 
51 Did you drink any alcohol? 
(If “yes”, proceed to Question 52.   
If “no”, skip Questions 52-53; continue with Question 54.) 
     Yes 
     No 
52 If yes, how many times did you drink per week? 
 Once per week or less 
 Two to three times per week 
    Four to six times per week 
    Daily 
53 How many drinks did you have per episode? 
 < 2 
     2 to 3 
     4 or more 
     If > 4, please specify average 
     number: ________________ 
SECOND TRIMESTER (13-24 weeks)     Tick the most appropriate answer.
54 Did you drink any alcohol? 
(If “yes”, proceed to Question 55.   
If “no”, skip Questions 55-56; continue with Question 57.) 
     Yes 
     No 
55 If yes, how many times did you drink per week? 
 Once per week or less 
 Two to three times per week 
    Four to six times per week 
    Daily 
56 How many drinks did you have per episode? 
 < 2 
     2 to 3 
     4 or more 
     If > 4, please specify average 
     number: ________________ 
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THIRD TRIMESTER (24-40 weeks)     Tick the most appropriate answer. 
57 Did you drink any alcohol? 
(If “yes”, proceed to Question 58.   
If “no”, skip Questions 58-59; continue with Question 60.) 
     Yes 
     No 
58 If yes, how many times did you drink per week? 
 Once per week or less 
 Two to three times per week 
    Four to six times per week 
    Daily 
59 How many drinks did you have per episode? 
 < 2 
     2 to 3 
     4 or more 
     If > 4, please specify average 
     number: ________________ 
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SMOKING 
FIRST TRIMESTER (0-12 weeks)     Tick the most appropriate answer.
60 Did you smoke? 
(If “yes”, proceed to Question 61.   
If “no”, skip Question 61; continue with Question 62.) 
     Yes 
     No 
61 If yes, how many cigarettes did you smoke per day? 
 10 or less 
 11 to 20 
    21 to 30 
    More than 30 
SECOND TRIMESTER (13-24 weeks)     Tick the most appropriate answer. 
62 Did you smoke? 
(If “yes”, proceed to Question 63.   
If “no”, skip Question 63; continue with Question 64.) 
     Yes 
     No 
63 If yes, how many cigarettes did you smoke per day? 
 10 or less 
 11 to 20 
    21 to 30 
    More than 30 
THIRD TRIMESTER (24-40 weeks)     Tick the most appropriate answer.
64 Did you smoke? 
(If “yes”, proceed to Question 65.  
If “no”, skip Question 65.) 
     Yes 
     No 
65 If yes, how many cigarettes did you smoke per day? 
 10 or less 
 11 to 20 
    21 to 30 
    More than 30 
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Informed Consent Form 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT 
FORM FOR USE BY PARENTS/LEGAL GUARDIANS 
Children Control Version 
 
 
TITLE OF THE RESEARCH PROJECT: 
STRUCTURAL NEURO-IMAGING AND NEURO-COGNITIVE CORRELATES IN 
PRENATALLY METHAMPHETAMINE EXPOSED CHILDREN IN CAPE TOWN. 
 
REFERENCE NUMBER: HREC 235/2009 
 
PRINCIPAL INVESTIGATOR: Dr Kirsty Donald 
 
ADDRESS: School of Child and Adolescent Health, Red Cross Children’s Hospital 
and the University of Cape Town 
 
CONTACT NUMBER: (021) 6585322 
Your child is being invited to take part in a research project.  Please take some time to 
read the information presented here, which will explain the details of this project.  
Please ask the study staff or doctor any questions about any part of this project that you 
do not fully understand.  It is very important that you are fully satisfied that you clearly 
understand what this research entails and how your child could be involved.  Also, your 
child’s participation is entirely voluntary and you are free to decline to participate.  If 
you say no, this will not affect you or your child negatively in any way whatsoever.  You 
are also free to withdraw him/her from the study at any point, even if you do initially 
agree to let him/her take part. 
 
This study has been approved by the Committee for Human Research at the 
University of Cape Town and will be conducted according to the ethical guidelines 
and principles of the international Declaration of Helsinki, South African Guidelines 
for Good Clinical Practice and the Medical Research Council (MRC) Ethical 
Guidelines for Research. 
 
 
What is this research study all about? 
This study looks at the structure of your child’s brain using a brain scan (Magnetic 
resonance imaging) and by doing some tests of learning.  By doing so we hope to get a 
better understanding of how the brain looks and also what goes wrong in certain 





Why has your child been invited to participate? 
Previously we tested your child’s development and we would now like to look at the 
structure of his/her brain as well as to do some further tests of learning and behaviour. 
 
What will your responsibilities be? 
You would be required to bring your child to the unit so we can get the images and wait 
with your child while we are scanning. Your child will also be given an assessment of 
learning on a different day at the Red Cross Children’s Hospital. Each session will take 1-
2 hours in total. There will be one set of assessments this year and another (similar) set 
in a year’s time. 
 
Will your child benefit from taking part in this research? 
An assessment of your child’s learning will be done and brain scanned. Possible 
problems may be picked up early and your child will be referred for treatment. 
 
Are there any risks involved in your child taking part in this research? 
No. Your child may become bored and not find this enjoyable but they will 
experience no pain. If at any time they become upset and do not wish to continue, 
the task will be stopped. 
 
Who will have access to your child’s medical records? 
Only members of the research team will have access to the data gathered here. All 
information will remain confidential and if the results of this study are published no 
participant will be identified. 
 
 
Will you or your child be paid to take part in this study and are there any costs 
involved? 
You or your child will not be paid to take part in the study, but your/your child’s 
transport and meal costs will be covered for each study visit.  There will be no costs 
involved for you if your child does take part. 
 
 
Is there any thing else that you should know or do? 
 You should inform your family practitioner or usual doctor that your child is 
taking part in a research study.   
 You can contact Dr Kirsty Donald at tel 021-6585322 if you have any further 
queries or encounter any problems. 
 You can contact the Committee for Human Research if you have any 
concerns or complaints that have not been adequately addressed by your 
child’s study doctor. 







Assent of minor 
 
I (Name of Child/Minor)………………………………………………. have been invited 
to take part in the above research project.  
 
 The study doctor/nurse and my parents have explained the details of the 
study to me and I understand what they have said to me. 
 They have also explained that this study will involve. I also know that I am 
free to withdraw from the study at any time if I am unhappy. 
 By writing my name below, I voluntary agree to take part in this research 
project.  I confirm that I have not been forced either by my parents or 




   ......................................................  
Name of child Independent witness 




Declaration by parent/legal guardian 
 
By signing below, I (name of parent/legal guardian) …………………………………...……. agree 
to allow my child (name of child) ………………………………….… who is ………. years old, to 
take part in a research study entitled (insert title of study) 
 
I declare that: 
 
 I have read or had read to me this information and consent form and that it is 
written in a language with which I am fluent and comfortable. 
 If my child is older then 7 years, he/she must agree to take part in the study 
and his/her ASSENT must be recorded on this form. 
 I have had a chance to ask questions and all my questions have been 
adequately answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to let my child take part. 
 I may choose to withdraw my child from the study at any time and my child 
will not be penalised or prejudiced in any way. 
 My child may be asked to leave the study before it has finished if the study 
doctor or researcher feels it is in my child’s best interests, or if my child does 










   ......................................................  





Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer 
them. 
 I am satisfied that he/she adequately understand all aspects of the research, as 
discussed above 
 I did/did not use a translator (if a translator is used, then the translator must 
sign the declaration below). 
 
 




   ......................................................  
Signature of investigator Signature of witness 
 
 
Declaration by translator 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) ………….…………………………. to explain the 
information in this document to (name of parent/legal 
guardian) ……...………………………... using the language medium of 
Afrikaans/Xhosa. 





 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the parent/legal guardian fully understands the content of 








   ......................................................  








Informed Assent Form 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT 
FORM FOR USE BY PARENTS/LEGAL GUARDIANS 
Children Patient Version 
 
 
TITLE OF THE RESEARCH PROJECT: 
STRUCTURAL NEURO-IMAGING AND NEURO-COGNITIVE CORRELATES IN 
PRENATALLY METHAMPHETAMINE EXPOSED CHILDREN IN CAPE TOWN. 
REFERENCE NUMBER: HREC 235/2009 
 
PRINCIPAL INVESTIGATOR: Dr Kirsty Donald 
 
ADDRESS: School of Child and Adolescent Health, Red Cross Children’s Hospital 
and the University of Cape Town 
 
CONTACT NUMBER: (021) 6585322 
 
Your child is being invited to take part in a research project.  Please take some time to 
read the information presented here, which will explain the details of this project.  
Please ask the study staff or doctor any questions about any part of this project that you 
do not fully understand.  It is very important that you are fully satisfied that you clearly 
understand what this research entails and how your child could be involved.  Also, your 
child’s participation is entirely voluntary and you are free to decline to participate.  If 
you say no, this will not affect you or your child negatively in any way whatsoever.  You 
are also free to withdraw him/her from the study at any point, even if you do initially 
agree to let him/her take part. 
 
This study has been approved by the Committee for Human Research at 
University of Cape Town and will be conducted according to the ethical guidelines 
and principles of the international Declaration of Helsinki, South African Guidelines 
for Good Clinical Practice and the Medical Research Council (MRC) Ethical 
Guidelines for Research. 
 
 
What is this research study all about? 
This study looks at the structure of your child’s brain using a brain scan (Magnetic 
resonance imaging) and by doing some tests of learning and behaviour.  By doing so we 
hope to get a better understanding of how the brain looks as well as how a child learns 
and also what goes wrong in certain disorders so (in the long term) we can identify 





Why has your child been invited to participate? 
We would like to get a better understanding of brain structure as well as the way 
children learn and behave who have been exposed to a substance such as 
Methamphetamine (‘Tik’), with the aim of eventually improving diagnosis and 
treatment options. 
 
What will your responsibilities be? 
You would be required to bring your child to the unit so we can get the images and wait 
with your child while we are scanning. Your child will also be given an assessment of 
learning on a different day at the Red Cross Children’s Hospital. Each session will take 1-
2 hours in total. There will be one set of assessments this year and another (similar) set 
in a year’s time. 
 
Will your child benefit from taking part in this research? 
Your child will receive a new type of brain scan as well as a report from the tests of 
learning. Any information obtained will be sent to your child’s doctor (with your 
consent). This may or may not aid in your child’s treatment. 
 
Are there any risks involved in your child taking part in this research? 
No. Your child may become bored and not find this enjoyable but they will 
experience no pain. If at any time they become upset and do not wish to continue, 
the task will be stopped. 
 
Who will have access to your child’s medical records? 
Only members of the research team will have access to the data gathered here. All 
information will remain confidential and if the results of this study are published no 
participant will be identified. We may require access to your child’s medical records. We 
will only ask for access to these records with your written permission. 
 
 
Will you or your child be paid to take part in this study and are there any costs 
involved? 
You or your child will not be paid to take part in the study, but your/your child’s 
transport and meal costs will be covered for each study visit.  There will be no costs 
involved for you if your child does take part. 
 
 
Is there any thing else that you should know or do? 
 You should inform your family practitioner or usual doctor that your child is 
taking part in a research study.   
 You can contact Dr Kirsty Donald tel 6585322 if you have any further queries 
or encounter any problems. 
 You can contact the Committee for Human Research at if you have any 
concerns or complaints that have not been adequately addressed by your 




 You will receive a copy of this information and consent form for your own 
records. 
 
Assent of minor 
 
I (Name of Child/Minor)………………………………………………. have been invited 
to take part in the above research project.  
 
 The study doctor/nurse and my parents have explained the details of the 
study to me and I understand what they have said to me. 
 They have also explained that this study will involve. I also know that I am 
free to withdraw from the study at any time if I am unhappy. 
 By writing my name below, I voluntary agree to take part in this research 
project.  I confirm that I have not been forced either by my parents or 




   ......................................................  
Name of  child Independent witness 
(To be written by the child if possible) 
 
 
Declaration by parent/legal guardian 
 
By signing below, I (name of parent/legal guardian) …………………………………...……. agree 
to allow my child (name of child) ………………………………….… who is ………. years old, to 
take part in a research study entitled (insert title of study) 
 
I declare that: 
 
 I have read or had read to me this information and consent form and that it is 
written in a language with which I am fluent and comfortable. 
 If my child is older then 7 years, he/she must agree to take part in the study 
and his/her ASSENT must be recorded on this form. 
 I have had a chance to ask questions and all my questions have been 
adequately answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to let my child take part. 
 I may choose to withdraw my child from the study at any time and my child 




 My child may be asked to leave the study before it has finished if the study 
doctor or researcher feels it is in my child’s best interests, or if my child does 
not follow the study plan as agreed to. 
 
 




   ......................................................  




Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer 
them. 
 I am satisfied that he/she adequately understand all aspects of the research, as 
discussed above 
 I did/did not use a translator (if a translator is used, then the translator must 
sign the declaration below). 
 
 




   ......................................................                 ................................................. 




Declaration by translator 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) ………….…………………………. to explain the 
information in this document to (name of parent/legal 





 We encouraged him/her to ask questions and took adequate time to answer 
them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the parent/legal guardian fully understands the content of 








   ......................................................                  ..................................... 




I declare that: 
 
I grant/do not grant the researcher permission to make my child’s results known to my 
treating doctor 
 




…………………………..                                                        ……………………… 
Signature  of Participant                                                       Signature of Witness.  
 
 
I declare that: 
 
I grant/do not grant the researcher permission to access my child’s medical records. 
 




…………………………..                                                                                           ……………………… 
 
Sigsnature of Participant                                                       Signature of Witness
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